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ABSTRACT
Use of high-throughput sequencing technology has revolutionized our ability to
study heart development and regeneration. However, extracting crucial information
from large-scale datasets is challenging. Here we demonstrated using bioinformatic
analysis to identify genetic features causing human cardiac arrhythmias, as well as key
components of heart regeneration.
Pitx2 is the homeobox gene located in proximity to the human 4q25 familial atrial
ﬁbrillation locus. Previous work focused onPitx2 developmental functions that predis-
pose to atrial ﬁbrillation. It is unknown whether Pitx2 has distinct postnatal functions.
Furthermore, it is unclear whether the 4q25 locus directly controls the expression of
Pitx2 via physical interaction that forms three-dimensional chromatin structure. Inac-
tivating Pitx2 in the postnatal atrium, unstressed adult Pitx2 homozygous mutant mice
display sinus node dysfunction, an atrial ﬁbrillation risk factor in human patients. An
integrated genomics approach revealed Pitx2 target genes encoding cell junction pro-
teins, ion channels, and critical transcriptional regulators. Importantly, many Pitx2
target genes have been implicated in human atrial ﬁbrillation by genome wide as-
sociation studies. Moreover, chromatin conformation capture sequencing (4C-Seq)
demonstrated a direct interaction of Pitx2 promoters and atrial-ﬁbrillation-associated
region.
The mammalian heart regenerates poorly, and damage commonly leads to heart
failure. Hippo signaling is kinase cascade that regulates organ size during develop-
ment and prevents adult mammalian cardiomyocyte regeneration by inhibiting the
transcription factor Yap. To identify Yap target genes that are activated during car-
diomyocyte renewal and regeneration, we performedYap chromatin immunoprecipita-
ii
tion sequencing (ChIP-Seq) and mRNA expression proﬁling in Hippo-deﬁcient mouse
hearts. We found that Yap directly regulated genes encoding cell cycle progression pro-
teins, as well genes encoding proteins that promote F-actin polymerization and link the
actin cytoskeleton to the extracellular matrix. Border-zone cardiomyocytes of injured
Hippo-deﬁcient mouse hearts showed cellular protrusions, indicating cytoskeletal re-
modeling.
Our ﬁndings, revealing an independent postnatal role of Pitx2 in arrhythmias, un-
veil direct Pitx2 target genes that include channel and calcium handling genes as well
as genes that stabilize the intercalated disc in postnatal atrium. In the context of mam-
malian cardiomyocyte regeneration, in addition to activating cell cycle genes, Yap
regulated genes enhance cytoskeletal remodeling and the cellular response to local
mechanical microenvironment.
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1. INTRODUCTION AND LITERATURE REVIEW
Use of high-throughput sequencing technology has revolutionized our ability to
study heart development. On an unprecedented scale, it allows investigators to pre-
cisely measure gene expression, as well as to pinpoint cis-regulatory elements. Ac-
cordingly, investigators are adopting a new perspective—studying developmental pro-
cesses and disease conditions in a more systematic and unbiased fashion. Therefore,
the outcome of such studies is largely dependent on our ability to use bioinformatic
tools extracting crucial information from large-scale datasets. In general, we solve a
biological problem by following a series of sequential steps: starting with the identiﬁ-
cation of key elements from individual datasets; then bridging key elements from one
dataset to another; next, manipulating one system and observing the consequences;
lastly, applying the implication from one system to another and testing the hypothesis
experimentally.
In this dissertation, I will use two examples to explain this thought process (Figure
1.1). First, I will describe the comparison of genomic information between humans and
mice. We searched for genetic features causing human cardiac arrhythmias, and tested
this hypothesis in a mouse model. Second, I will demonstrate an integrative bioin-
formatic analysis that reveals gene expression patterns across developmental stages,
which leads us to identify key components of heart regeneration.
1.1 Gene expression proﬁling in cardiac development processes and disease
conditions
The Encyclopedia of DNA Elements (ENCODE) project estimated that over 60%
of the human genome is transcribed into RNA [33]. Polyadenylated RNA-Sequencing
is most commonly used to proﬁle messenger RNA (mRNA) transcription, including
1
Figure 1.1: Approaches to identify function genomic features. Bridging existing
knowledge to unknowns is the key to identify genomic feature.
the majority of the protein coding genes, which cover only 2.9% of the genome [33].
Currently (May 2015), at least 50 RNA-Seq-based studies done by using cardiac
tissue, primary cells, or cell lines, are publicly available on Gene Expression Omnibus
(GEO) database. These datasets represent different aspects of cardiac development
and diseases, such as gene expression proﬁling of different developmental stages, ge-
netic knockout models, disease models, in vitro cardiomyocyte (CM) differentiation,
and different subtypes of the heart tissue. These datasets also cover the cardiac tran-
scriptome from awide range of species, including human (Homo sapiens), mouse (Mus
musculus), zebraﬁsh (Danio rerio), rats (Rattus norvegicus), rhesus macaque (Macaca
mulatta), chicken (Gallus gallus), sheep (Ovis aries) and so on, which will allow us to
discover conserved gene expression programs in heart development. The integrative
bioinformatic analysis of these individual studies is challenging. For example, it is crit-
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ical to select proper methods for normalizing data from different sources. Nonetheless,
a comprehensive bioinformatic analysis that integrates individual dataset will provide
us valuable information on the dynamic gene transcription process of heart develop-
ment and disease conditions.
1.2 Temporal gene expression in heart development
Heart formation is well-controlled temporally. In mice, it only takes six days to
develop from the primitive streak (mouse embryonic day 6.0, E6.0) to a four-chamber
heart (around E12.5) [112]. It requires precise genetic regulation for progenitor cell to
properly proliferate and migrate into future heart ﬁelds; to form left-right asymmetri-
cal pattern; to determine cell fate and to differentiate into multiple lineages. Emerg-
ing evidence indicates that lineage-speciﬁc transcription factors (TFs) and signaling
molecules orchestrate this drastic morphological change. RNA-Seq datasets taken
from snapshots of multiple developmental stages (Table 1.1) summarize the tempo-
ral expression pattern of cardiac TFs and signaling molecules. These high-throughput
datasets recapitulate the discoveries from decades of elegant work using morpholog-
ical and gene disruption strategies. More importantly, RNA-Seq datasets will unveil
novel candidate regulators that have important functions, yet have been missed by tra-
ditional methods.
The best evidence to support the idea that TFs are drivers of robust gene expression
and cardiogenesis is using signaling molecules and TFs to progressively differentiate
embryonic stem cells (ESCs) to cardiomyocytes (CMs) in vitro [91, 59]. The initial
efforts to derive cardiomyocytes from murine and human ESCs [112] attempted to re-
produce interactions between germ layers through the formation of three-dimensional
clusters, termed embryoid bodies, using serum stimulation and suspension culture.
Spontaneously contracting CMs typically arise within 4 to 8 days after plating those
3
Table 1.1: Summary of RNA-Seq datasets from cardiac tissue and primary cells.
Tissue / Cell line Stage / Cell type Data references
mouse cardiac progenitors E4.75 GSE58363 [26]
mouse whole heart
E9.5 GSE63813
E10.5 GSE56902 [35]
E11.5 GSE58157 [145]
E12.5 GSE61209
mouse ventricle E14.5 [147]
mouse ventricle, CM and CF E17, P1, P10, P28, P90 GSE49906 [38]
mouse whole heart P56 GSE49417 [151]
mouse atria E18.5 GSE52080 [92]
human atria adult GSE31999 [52]
human whole heart adult GSE49417 [151]
human ventricle adult ISCH, DCM GSE57344 [80]
human ventricle adult ISCH, DCM GSE55296 [129]
human ventricle adult ISCH GSE48166
mouse ventricle and CM P0, P4, P7, apex resection GSE64403 [97]
in vitro differentiated CM day 0, 4, 5, 10 GSE47950 [136]
mouse TRAP cTnT-, Tie2-Cre adult TAC GSE45152 [155]
E: Embryonic day
P: postnatal day
CM: cardiomyocyte
CF: cardiac ﬁbroblast
ISCH: ischemic heart disease
DCM: dilated cardiomyopathy
TRAP: translating ribosome afﬁnity puriﬁcation
TAC: transaortic constriction
4
embryoid bodies. Although this strategy is simple and reproducible, the yield of CMs
is low. The total number of CMs generated from each mouse embryoid body is about
1-5% of total cells; only 0.1-1% from human ESCs. Cued by genetic principles iden-
tiﬁed from heart development, Kattman et al [59] used Activin and BMP4 to induce
dissociated mouse embryoid body cells to become Flk1 and PdgfR-α double positive
cells. Furthermore, they treated these cardiogenic mesodermal cells with VEGF and
FGF and observed 70% cardiac Troponin T (cTnT)-positive cells [136]. The differen-
tiating cells were highly enriched with mesodermal markers (Mesp1 and Brachyury) at
day 4, cardiac TFs (Nkx2-5, Tbx5 and Isl1) at day 5 and CM-speciﬁc genes (Myh6 and
Myh7) by day 10. RNA-Seq analysis revealed a close correlation between the expres-
sion proﬁles of these differentiating cells and that observed in vivo [136]. Although
the differentiated CMs have immature characteristics, for example,Myh7 is highly ex-
pressed at day 10 stage, the protocol still proves to be a promising model for studying
CM differentiation and gene regulatory networks.
CM differentiation process does not stop after heart formation. Once the primitive
embryonic heart is formed, CMs undergo morphological and physiological matura-
tion. By comparing E17 to adult ventricles, Giudice et al [38] showed that extensive
gene expression change happen within the ﬁrst 4 weeks after birth. The expression
of genes involved in cell cycle and DNA replication are signiﬁcantly reduced postna-
tally, which is consistent with a low proliferation rate and poor regenerative capacity
of adult CM [102, 97]. Adult heart transcriptome shows enrichment of genes related to
mitochondrial function, fatty-acid metabolism, and oxidation-reduction process, mir-
rors the metabolic switch from glycolysis to lipid oxidation that occurs after birth.
Furthermore, Puente et al [103] connected the metabolism pathway to gene program
involved in CM cell cycle; demonstrated the oxygen-rich postnatal environment is the
upstream signal of CM cell-cycle arrest; and suggested reduction of mitochondrial-
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dependent oxidative stress is an important component to ensure CM re-enter cell-cycle
in cardiac regeneration.
1.3 Tissue and cell type speciﬁc transcriptome
Adult heart is a mixture of multiple cell lineages and differentiated cell types. The
non-CMs, which consist of ﬁbroblast, endothelial cells, and smooth muscle cells, are
derived from multiple sources: epicardium, endocardium, and neural crest. The ﬂow-
cytometry-based studies done in rat and mouse suggest the heart is composed of 50-
70% non-CM and 30-50% CM. Since RNA extracted from whole heart represents the
average transcript level from both CMs and non-CMs, measure of transcriptome from
whole tissue will result in loss of tissue-speciﬁc information or mistakenly assign gene
expression from one cell type to another. Therefore, it is important to extract tissue-
or cell type-speciﬁc transcriptome in order to address how different cell types coordi-
nate with each other while maintaining their distinctive identities. Three strategies are
commonly used:
(a) Cellular dissociation. The majority of non-CMs are cardiac ﬁbroblasts (CFs)
that are often isolated by differential attachment assay, a method that takes advantage
of the shorter attachment time of CFs after Langendorff perfusion and cellular dissoci-
ation. Giudice et al [38] used differential attachment method to separate CMs and CFs
and performed RNA-Seq across multiple postnatal stages. Interestingly, transcriptome
analysis demonstrated a dramatic increase in mature CM gene expression signatures
during postnatal stages. However, CF enriched transcripts maintained constant ratios
during development, suggesting a different maturation process between CM and CF
[38]. To separate embryonic epicardial cells, Xiao et al [147] placed E13.5 ventricles
in a type I collagen-coated dish for 24 hours. The epicardial cells migrated and formed
a monolayer colony on the dish. RNA-Seq analysis revealed that the murine epicar-
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dial cells are expressing mesenchymal stem cell surface markers (Sca1, Cd44, Cd90,
Cd49e, Cd51, and Cd81) [20]. Furthermore, these cells have differentiation potential
for endothelial, smooth muscle and ﬁbroblast lineages.
(b) Regional dissection. Cardiac conduction system is essentiallymyocardial [112].
The sinoatrial node (SAN) is the primary pacemaking component that generates the
electric impulse. In the mature heart, the SAN is located at the junction of the superior
caval vein and right atrium. The electric impulse propagates rapidly through right atrial
muscle and slowly through the atrioventricular (AV) node, located in the bottom of the
right atrium [112]. Given the anatomical differences, left and right atria have distinct
susceptibilities towards developing arrhythmias, with left atrial arrhythmias are more
common. Gene expression differences established during development are maintained
in adulthood, examples include PITX2 enriched in the left atria and BMP10 in the right
atria [52]. Vedantham et al [133] used laser capture micro-dissection (LCM) to isolate
RNA from pacemaker cells for RNA-Seq. Differential gene expression and network
analysis identiﬁed that the TF Isl1 is active in developing pacemaker cells with a major
role in SAN establishment.
(c) Genetic tagging. While cellular dissociation and regional dissection methods
are extremely useful methods to isolate a speciﬁc cell population, both methods have
their shortcomings: the former alters physical environment that maintained in vivo;
the latter hardly allows a clean separation of different cell types. In contrast, genetic
tagging methods enriches RNA by lineage-speciﬁc labeling and pull-down, without
disrupting native homeostasis of the cells. Zhou et al [155] generated a mouse line
with lineage-selective Cre actives the expression of GFP fused ribosomal L10a pro-
tein, allowing isolation of genetically tagged ribosomes (translating ribosome afﬁnity
puriﬁcation; TRAP). By using Tie2-Cre and cTnt-Cre, endothelial and CM-speciﬁc
transcripts were enriched in the substrates of GFP-immunoprecipitation, respectively.
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Besides the listing common strategies, newly developed technologies, such as single-
cell RNA-Seq [46, 55] and in situRNA-Seq [67] enable massive parallel transcriptome
analysis in single-cell resolution, will be extremely useful to advance our understand-
ing in cellular and spatial organization of gene expression programs in heart develop-
ment and diseases.
1.4 Transcriptome analysis in disease conditions
Heart failure, caused by massive CM loss, is the number one cause of death world-
wide. Two of the most common subtypes of heart failure are ischemic heart disease
(ISCH) and dilated cardiomyopathy (DCM). Although these two subtypes lead to sim-
ilar outcomes, they have completely divergent functional and phenotypic progression.
Hence, the distinct molecular characterization of these disease conditions is the key
for understanding the progression of heart failure and offering therapeutic solutions.
Multiple groups have reported gene expression proﬁling studies in human ISCH
and DCM patients, and showed distinct gene expression signatures between ISCH and
DCM [65, 129, 80]. However, interpretation of human data is challenging, due to
limited sample size, proper gender and age controls, ethnic backgrounds, and varied
co-morbidities. Thus multiple heart injury models have been developed for study-
ing pathology of the disease and regeneration. Through ligation of the left anterior
descending coronary artery, myocardium infarction (MI) achieves acute infarction in
about two weeks. The expression of cardiac stress genes (Nppa, Nppb, Myh6) and
ﬁbrosis genes (Col1a1, Postn and Tgfβ1) are increased in the failing hearts two weeks
after MI [98].
Transaortic constriction (TAC) as a model of heart failure, mimics the pressure
overload-induced cardiac hypertrophy at one week, and dilated cardiomyopathy at 8
week. Lee et al [68] collected left ventricle RNA from hypertrophy and DCM samples,
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and found increased expression of genes involved in vascular remodeling, inﬂamma-
tory response, and ﬁbrosis. They also discovered differentially expressed isoforms in
TAC conditions compared to sham controls.
Although the transcriptome analysis of murine failing hearts provides valuable in-
sights in molecular changes of heart remodeling, two major shortcomings are notice-
able. Firstly, the failing hearts are mostly ﬁbrotic tissue, limiting our ability to dissect
speciﬁc gene expression proﬁle from individual cell types. Thus cell-type-speciﬁc
enrichment, such as lineage speciﬁc RNA pull-down methods should be considered.
Secondly, more intermediate stages are needed to capture molecular changes before
signiﬁcant cellular remodeling happens.
The mammalian heart maintains regeneration capability in a short window after
birth. Neonatal mice can fully regenerate their hearts following ventricular apex re-
section [102]. Genetic mapping showed the regenerating tissue are from existing CM,
instead of a resident stem cell or progenitor population. O’Meara et al [97] compared
neonatal ventricle, as well as puriﬁed CM following apex resection, and found that CM
de-differentiated to a primitive stage. The increased gene expression program included
reactivation of cell cycle and developmental genes.
Beside heart failure, cardiac arrhythmia is another common disease in clinic. The
molecular mechanisms underlying the early development of atrial ﬁbrillation (AF) re-
mains unclear. Chiang et al [18] performed RNA-Seq using right atrial appendage
samples from paroxysmal AF patients and found the expression of inﬂammatory re-
lated signaling pathway were increased. Furthermore, they discussed the potential
involvement of the gonadotropin releasing hormone receptor and p53 pathways in AF
pathogenesis. However, the study has limited sample size and only right atrial samples
were obtained.
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1.5 Dark matter of the transcriptome
Analysis of polyadenylated enriched RNA-Seq is largely dependent on bioinfor-
matic tools and genome annotations. Existing RNA-Seq analysis tools can be grouped
into two classes: transcript-based assembly and differential expression analysis tools
and exon-based quantiﬁcation tools. First group included assembly tools like TopHat
and Cufﬂinks [62], which assemble RNA-Seq reads to individual transcripts based on
splice junctions from either reference annotation or using a de novo assembly algo-
rithm. The advantage of this method is that the abundance of different isoforms is
reported. In particular, the de novo assembly algorithm enables the detection of novel
transcripts and alternative splicing events. However, this method requires a large num-
ber of sequencing reads to accurately predict splice junctions. By contrast, the tools
in the second group, such as HTSeq [4], count the raw reads based on individual ex-
ons. The quantiﬁcation of gene expression is reported based on sum of all the exons
in a particular gene, not transcript. Ambiguity arises when multiple gene bodies are
overlaid with each other. The most common solutions are either to arbitrarily assign
the reads to either gene, or to simply discard the reads. Therefore approximately 50%
of the reads from a given RNA-Seq experiment will not be annotated by these tools.
What makes up the remaining transcriptome? Long non-coding RNAs (lncRNAs)
are RNA transcripts longer than 200 nt, often poly-adenylated and 5’-capped, with
lower expression levels and less conservation compared to protein-coding RNAs [42].
Interestingly, large-scale RNAi screening showed that lncRNA function in ESC differ-
entiation [43]. Klattenhoff et al [64] and Grote et al [40] identiﬁed lncRNAs necessary
for specifying the cardiac lineage. Speciﬁcally depletion of Braveheart, a lncRNA
which regulates Mesp1 through physically interacting with component of polycomb-
repressive complex (PRC), resulted in CM differentiation defects in vitro. Similarly,
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Fendrr, a lncRNA which represses PRC, and promotes cardiac-speciﬁc gene expres-
sion. In addition, Han et al [45] demonstrated Myheart, an anti-sense transcript of
Myh7, predominately expressed in the nucleus, prevents chromatin from remodeling
following cardiac hypertrophy. Thus these studies indicate the importance of lncRNA
during cardiac lineage commitment and disease conditions. However, all of these
lncRNAs are not annotated in the current version of the mouse genome. Only through
deep RNA-Seq can these lncRNAs be discovered.
The enhancer RNAs (eRNAs), present a group of novel and relative unstudied short
non-coding RNAs. Wu et al [145] identiﬁed over 3,000 eRNA expression in themouse
heart, which globally correlate with tissue-speciﬁc enhancer activity. Given that a large
amount of eRNA do not contain poly-adenylated tails, poly-adenylated enriched RNA-
Seq can therefore only detect a small proportion of the total eRNAs. One solution
to discover novel eRNAs is to use total RNA-Seq. However, the sensitivity of total
RNA-Seq is largely affected by the abundant ribosomal RNA population. A better
strategy is to use global nuclear run-on sequencing (GRO-Seq), which captures nascent
RNA transcripts. Luo et al demonstrated that NF-κB associated eRNAs are turned
on in response to TNF-α stimulation in an immortalized adult ventricular CM cell
line, AC16. This suggests a potential role of eRNAs in the cis-regulatory network.
Therefore, GRO-Seq is a robust technique which may be applied towards investigating
the transcriptome dynamics occurring between transient stages, such as a intermediate
stages throughout heart regeneration.
Small non-coding RNAs (< 200 nt), including microRNAs and small nucleolar
RNAs (snoRNAs), are captured using size-selected RNA-Seq. Mature microRNA
sequences are highly conserved throughout all metazoans. MicroRNAs expressed in
the heart has been widely studied. Known cardiac enriched microRNAs include miR-
1, 133, 206, 208, 499, 17-92 and 106b [139]. By contrast, the function of snoRNAs
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Figure 1.2: Extended 3’ untranslated region in Nkx2-5. RNA-Seq were performed
using 8-week-old mouse heart. The forward and reverse strands are labeled as
‘+’ and ‘ ’, respectively. H3K36me3 ChIP-Seq from same tissue indicates active
transcription.
in heart is largely unknown. Our preliminary small RNA-Seq dataset from the heart
indicates that only 40% of reads are annotated. The functional analysis of unannotated
cardiac small RNA represents an unexplored frontier in this ﬁeld.
Alternative poly-adenylation (APA) is a pervasive mechanismwhich plays a part in
the regulation of most mammalian genes. The role of APA-mediated gene regulation
in heart development and diseases is just beginning to be appreciated. Xia et al [146]
used a novel bioinformatics-based algorithm to identify de novo APA from the Cancer
Genome Atlas (TCGA) RNA-Seq datasets, and found that most APA-regulated genes
have short 3’-UTRs. Since 3’-UTRs have been known harboring microRNA seed
sites, shortened 3’-UTRs indicate the potential loss ofmicroRNA-mediated repression.
Conversely, while examining through RNA-Seq data generated from heart tissue, we
found that a master cardiac regulator gene, Nkx2-5, has an unannotated transcript with
an extended 3’-UTR (Figure 1.2). Thus, we believe that a genome-wide categorization
of APA across developmental stages and disease states will reveal novel mechanisms
of cardiac gene regulation.
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Table 1.2: Histone modiﬁcation marks. Core set of ﬁve chromatin modiﬁcation marks.
Chromatin modiﬁcation Associated chromatin state
histone H3 lysine 4 trimethylation (H3K4me3) promoter regions
H3 lysine 4 monomethylation (H3K4me1) enhancer activity
H3 lysine 27 acetylation (H3K27ac) enhancer activity
H3 lysine 36 trimethylation (H3K36me3) transcribed regions
H3 lysine 27 trimethylation (H3K27me3) Polycomb repression
H3 lysine 9 trimethylation (H3K9me3) heterochromatin regions
1.6 Non-coding regulatory sequences
Before human genome project initiated, the estimated number of genes in human
genome ranged from 50,000 genes to as many as 140,000. With the completion of ﬁrst
draft of human genome, startling ﬁnding was the number of human genes is signiﬁ-
cantly fewer than previously estimated. In fact, both human genome and roundworm
(Caenorhabditis elegans) genome contain around 20,000 genes. Thus the complex-
ity of mammalian genomes does not related to their number of genes, instead 95% of
the mammlian genomes are non-coding regions [23, 110]. These non-coding regions
often harbor regulatory elements, such as enhancers that are sequences bound by TFs
and promoter gene expression via three-dimensional chromatin structures. With the
development of high-throughput sequencing technology, millions of potential regula-
tory elements are predicted by TFs binding sites and histone modiﬁcation signatures
(Table 1.2). Furthermore, chromatin conformation capture technology facilitates our
understanding of the complex and versatile mechanism underlying gene-enhancer se-
lection and the landscape of regulatory elements across the genome.
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1.7 Transcription factors
Transcription factors (TFs) are evolutionarily conserved and play key roles in cell-
fate speciﬁcation [51]. Pioneered by Yamanaka [127, 126], using only several ESC-
speciﬁc TFs (Oct3/4, Sox2, Klf4, and c-Myc) can induce differentiated cells to an em-
bryonic stem cell-like state. Similarly, by the addition of cardiac TFs, adult somatic
cells can be directly reprogrammed into cardiomyocyte-like cells, both in vitro and in
vivo [106, 105, 54]. The same concept is widely applied to non-CM cell types, for
example, to reprogram ﬁbroblast to endothelial-like cells [85].
The key role of TFs is to bind DNA elements and drive spatiotemporal pattern
of gene expression. ChIP-Seq, or chromatin-immunoprecipitation followed by deep
sequencing, has been widely adopted for studying genome-wide occupancy of TFs, as
well as histone modiﬁcations. So far, multiple ChIP-Seq datasets of key cardiac TFs
from murine hearts and cardiac related cell lines are available through GEO database
(see review: [137]). Interestingly, many of binding sites from different TFs are co-
localized together, especially in the open chromatin regions that are marked by Dnas
I hypersensitive sites (DHS) and enhancer regions marked by H3K4me1, H3K27ac
and p300 ChIP-Seq. Furthermore, one TF can control expression of other TFs via cis-
regulation, indicating a well-organized transcriptional regulatory circuitry underlies
heart development [13].
Using bioinformatics algorithms, enriched TF binding peaks are detected by com-
paring either to an input dataset or locally over sequencing background. Size of the
ChIP-Seq peaks is commonly around 200-500bp. To assess the quality of ChIP-Seq
datasets, motif analysis is often required. Consensus sequence of TF binding site, or
motif, is expected to be centered and signiﬁcantly enriched in ChIP-Seq peaks. Such
consensus motifs were acquired both experimentally and computationally. Weirauch
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et al [142] broadly sampled DNA binding motifs from multiple eukaryotic clades and
determined DNA binding preferences of over 1000 TFs using an oligo array. Closely
related TFs almost always have similar DNA binding motifs. Moreover, multiple mo-
tifs are often enriched in one ChIP-Seq experiment, indicating potential co-factors are
binding to same locations with the factor of interest.
1.8 DnaseI hypersensitive sites and enhancers
DHS, denoting accessible chromatin regions, are the indicators of open chromatin.
Regulators associated to these regions include TFs, histone modiﬁcation marks, chro-
matin insulators, cohesin complex, and lamina-associated domains. High-coverage
DHS-Seq, or digital genomic foot-printing (DGF) [110], uses computational methods
to search for tissue-speciﬁc TF binding sites. The epigenetic roadmap project provides
DHS-Seq from human and mouse heart, which are valuable references for genome-
wide epigenetic states in heart. However, DHS-Seq is technically challenging —its
protocol requires large amount of tissue and involves low-efﬁcient steps. Recently, a
transposase-based assay, transposase-accessible chromatin using sequencing (ATAC-
Seq), was developed for capturing open chromatin sites with easier protocol and higher
sensitivity.
Enhancers are distal regulatory elements that can activate tissue-speciﬁc gene ex-
pression and are abundant throughout mammalian genome [96]. Using H3K27ac as a
mark of active enhancers, Nord et al [96] identiﬁed over 90,000 enhancers across three
different mouse tissues. Most of these enhancers exhibited tightly restricted temporal
and spatial activity. In addition, the transgenic mouse assay exhibited 12/18 (67%) of
tested enhancer drove reproducible expression pattern in vivo. Using an in vitro dif-
ferential protocol, Wamstad et al [136] identiﬁed highly correlated patterns between
gene expression and epigenetic modiﬁcation. They further identiﬁed stage-speciﬁc
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distal enhancer elements and found that binding motifs of driver TFs were enriched in
these enhancers.
Overall, high-throughput sequence technology opens up a new era in biology re-
search. Publication of a dataset no longer means the end of the study, but an addition
of valuable resource to the community. Empowered by integrated bioinformatic anal-
ysis, high-quality datasets will be mined again and again. The discovery from highly
integrated analysis will advance our understanding of origins of the heart, will unveil
the cause of diseases, and will shed light on novel therapeutic targets.
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2. PITX2 DIRECTLY TARGETS ION TRANSPORT AND INTERCALATED
DISC GENES*
Atrial ﬁbrillation (AF), the most prevalent adult arrhythmia in humans, results in
an increased risk of stroke, dementia, and heart failure [10]. Electric impulses that are
critical for a coordinated, physiological heartbeat originate in the sinoatrial node and
are transduced from the pacemaker region into both atria. In AF, ﬁbrillatory atrial im-
pulses override normal conduction pathways with resulting irregular ventricular con-
duction.
Because of its clinical signiﬁcance, great efforts have been expended to investi-
gate the genetic underpinnings of AF using unbiased genome-wide approaches such
as genome-wide association study (GWAS). Multiple studies have revealed a single-
nucleotide variant on human 4q25 that was associated with familial AF [84]. Patients
with the 4q25 variant exhibited early onset AF that was independent from known AF
risk factors. The 4q25 single-nucleotide variant also had prognostic value because
patients with this variant are prone to AF recurrence after ablation therapy [53]. The
gene-poor 4q25 region harbors the Pitx2 homeobox gene, which has been implicated
in AF predisposition using mouse models [138, 19, 63, 2].
Pitx2, a transcription factor that controls transcription of numerous target genes,
is located in proximity to sequence variants in the human genome that are commonly
associated with atrial ﬁbrillation (AF). Although previous work focused on Pitx2 dur-
ing development, the current study investigated Pitx2 in postnatal heart. It was un-
known previously whether Pitx2 has distinct postnatal and developmental functions.
*Reprinted with permission from “Pitx2, an atrial ﬁbrillation predisposition gene, directly regulates
ion transport and intercalated disc genes” by Y. Tao, M. Zhang, L. Li, Y. Bai, Y. Zhou, A. M. Moon,
H. J. Kaminski, J. F. Martin. Circulation: Cardiovascular Genetics, 1(7):23-32, Feb 2014. Wolters
Kluwer Health Lippincott Williams & Wilkins©. No modiﬁcations will be permitted.
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The Pitx2 genes were removed from hearts of postnatal mice. Unstressed adult Pitx2
mutant mice display arrhythmias called sinus node dysfunction, an AF risk factor
in human patients. To uncover target genes that are regulated by Pitx2, we used a
genome-wide approach to identify all cardiac genes that are regulated by Pitx2. Pitx2
target genes encoded cell junction proteins, ion channels, and critical transcriptional
regulators. Importantly, many Pitx2 target genes have been implicated previously in
human AF. Other studies in adult Pitx2mutant mice revealed structural remodeling in
the heart characteristic of human patients with AF. Our ﬁndings provide new mech-
anistic insight into AF, revealing that Pitx2 has genetically separable postnatal and
developmental functions and unveiling direct Pitx2 target genes that include channel
and calcium handling genes, as well as genes that stabilize the cellular structure in
postnatal atrium. Because Pitx2 regulates many of these genes in the postnatal heart,
it is conceivable that drugs can be developed to modulate the molecular interaction
between Pitx2 and its target genes. Our ﬁndings that many important Pitx2-regulated
events occur postnatally also strengthens the likelihood that Pitx2-mediated AF may
be treatable in the future.
2.1 AF and associated arrhythmias
AF may result from new, pathological sources of electric impulses. For example,
many cases of ectopic electric activity originate in the pulmonary vein [44]. Other
sites of ectopy include the left atrial posterior wall, superior vena cava, interatrial sep-
tum, crista terminalis, and coronary sinus myocardium [58, 74]. In addition to ectopy,
other causes of AF involve atrial myopathy that disrupts normal atrial conduction and
promotes re-entrant circuits. One common example of AF secondary to myopathy is
ﬁbrosis that in some cases may be because of elevated transforming growth factor-β
signaling [34].
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Work from the Framingham study has shown that patients with PR interval pro-
longation, also called ﬁrst-degree atrioventricular block, often develop AF [17]. In
addition to atrioventricular block, sinus node dysfunction (SND) is also an AF risk
factor in human patients [111]. Notably, progression to higher grade arrhythmias with
time is also common, reﬂecting the importance of aging in arrhythmogenesis. Al-
though the mechanistic connection among SND, PR interval prolongation, and AF are
poorly understood, all three conditions may involve an atrial myopathy with defective
atrial impulse conduction [69].
Predisposition to AFmay result from a developmental defect that results in an adult
heart with subclinical abnormalities that subsequently manifest as overt disease after
environmental insults or aging. Alternatively, postnatal homeostatic genes may be
required to maintain normal tissue structure and physiology. Small changes in home-
ostatic gene level may result in subclinical disease until an AF-inducing stress is en-
countered.
2.2 Pitx2 and predisposition to AF
Pitx2 encodes 3 isoforms, Pitx2a, Pitx2b, and Pitx2c, that are generated by alter-
native splicing and dual promoter usage [138]. Pitx2c is generated via an intergenic
promoter, whereas the Pitx2a and Pitx2b isoforms that are generated by alternative
splicing use an upstream 5’ ﬂanking promoter. The Pitx2c isoform is expressed on the
left side of the embryo, whereas the Pitx2a and Pitx2b isoforms are expressed symmet-
rically in the head within the eyes and craniofacial structures [138]. In mouse, Pitx2c
expression continues in the postnatal atrium, whereas human PITX2C is also the pre-
dominant isoform in the left atrium [138, 63, 52]. Studies in isoform-speciﬁc knockout
mice in our laboratory also revealed that the Pitx2c isoform is the dominant isoform
in determining left right asymmetry during development [77]. Pitx2 haploinsufﬁcient
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(Pitx2null+/-) adult mice and Pitx2c+/- adult mice were prone to AF when challenged
by programmed stimulation, indicating that reduced Pitx2c levels during development
create an arrhythmogenic substrate [138, 63]. Notably, Pitx2 levels are also decreased
in the atria of human patients with AF [19].
Previous experiments indicated that sinoatrial node genes were expanded in left
superior caval vein and left atrium of Pitx2null/+ and Pitx2null/null mutant embryos, in-
dicating a developmental defect [138]. Optical mapping experiments showed Pitx2
conditional mutant embryos had a functional left-sided sinoatrial node that could over-
ride normal atrial cardiomyocyte depolarization [2]. Furthermore, Pitx2cheterozygous
adult mice had shortened action potential duration without ﬁbrosis or structural de-
fects, suggesting an electrophysiological mechanism for arrhythmogenesis in Pitx2c
germline mutants [63].
It is unknown whether Pitx2 has a postnatal homeostatic function. To study Pitx2
postnatal function, we generated a Pitx2 conditional knockout (CKO) mouse line that
deletes Pitx2 in postnatal atrium. The adult Pitx2 CKO mice had abnormal electro-
cardiography with irregular R–R interval and low-voltage P waves, indicating SND
with impaired atrial conduction. A genome-wide search for Pitx2 targets by ChIP-Seq
and microarray assays revealed genes encoding cell adhesion or cell junction proteins,
ion channels, and transcription factors. Many Pitx2 target genes are AF risk genes
identiﬁed in human GWAS [84]. Using immunoﬂuoresence and transmission electron
microscopy (TEM), we obtained evidence for structural remodeling of the intercalated
disc (ID), the structure that mediates cardiomyocyte electromechanical coupling [8].
Our data indicate a postnatal role for Pitx2 in AF predisposition and uncover novel
Pitx2 target genes that provide new mechanistic pathogeneses for AF.
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2.3 Results
2.3.1 Generation of Pitx2 CKO mice
To generate a Pitx2 conditional loss of function (Pitx2 CKO) allele that deletes
all Pitx2 isoforms in postnatal atrium, mice with theMCK-Cre driver were crossed to
mice bearing the Pitx2 conditional null (Flox) allele (Figure 2.1A). MCK-Cre directs
Cre activity in skeletal and cardiac muscle with a perinatal onset around birth [156, 14].
We examined Cre activity using the R26R LacZ reporter. MCK-Cre activity initiates
in atria after birth and within ventricles in a mosaic pattern after E15.5 (Figure 2.1B).
Because Pitx2 is predominantly expressed in left atrium at these fetal stages and in
adult, MCK-Cre is a valuable tool to address Pitx2 function in postnatal left atrium
[138, 77]. Both immunostaining and real-time reverse transcription PCR revealed that
Pitx2 was efﬁciently deleted in neonatal left atrium (Figure 2.1C&D). Although Pitx2
is also inactivated in skeletal muscle, we did not detect skeletal muscle phenotypes in
Pitx2 CKO mice perhaps because of overlapping function with Pitx3 [71].
2.3.2 Pitx2 CKO mice have abnormal cardiac conduction
We implanted telemetry transmitters into control and Pitx2 CKO adult mice and
collected resting electrocardiographic data in awake mice. Compared with normal
sinus rhythm in controls (Figure 2.2A), ECG tracing for Pitx2 CKO mice shows ab-
normal heart rate with irregular R–R intervals and low-voltage P waves (Figure 2.2B;
Table 2.1). This phenotype was observed in all Pitx2 CKO mice studied by resting
telemetry ECG but none of the controls (Table 2.2). Because sinus node sets heart
rhythm and P wave represents atrial depolarization, these phenotypes indicate SND
with impaired atrial conduction. Importantly, SND is closely associated with AF in
human patients [17].
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Figure 2.1: Generation of the Pitx2 conditional knockout mice. (A) Strategy for the
generation of the Pitx2 conditional knockout allele. Pitx2 Flox allele has two LoxP
sites ﬂanking exon 5, which encodes the N-terminus of DNA binding homeodomain.
Upon the activation of MCK-Cre, recombination between the two LoxP sites results
in the deletion of exon 5, thus generate the Pitx2 conditional knockout allele. (B)
Expression of MCK-Cre in the heart. MCK-Cre mice were mated to R26R mice to
generate progenies with the genotypeMCK-Cre R26R which express β-Galactosidase
(β-Gal) in the MCK-Cre expression domain. Hearts of embryos and pups from the
mating were collected and stained for β-Gal. Images of whole mount E17.5MCK-Cre
R26R embryonic heart and P2 heart are shown. In the E17.5 MCK-Cre R26R heart,
β-Gal staining was detected in the ventricles and was barely detected in the atria (left
panel). In P2 heart, β-Gal staining was detected in the whole heart (right panel). (C)
Immunoﬂuorescence staining for Pitx2 in the postnatal heart cells show expression
of Pitx2 in the nuclei of the control (Pitx2 Flox/Flox) heart cells and is nearly lost in
Pitx2 CKO heart. Nuclei of the heart cells were also labeled by TO-PRO-3 (TOP3).
Images show the staining in the left atria of the 3-month-old control (Pitx2 Flox/Flox) and
Pitx2 CKO (Pitx2 Flox/Flox MCK-Cre) mice. (D) Real time RT-PCR assay using primers
spanning exon 5 of Pitx2 transcripts shows Pitx2 expression level decreased over 80%
in the left atrium of P1 Pitx2 CKO heart. Values and error bars represent mean and
standard deviation (n = 3). Figure credit: Ye Tao
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Table 2.1: Abnormal R-R intervals in Pitx2 CKO mice. R-R interval were sampled
from uninterrupted one minute ECG tracing of control (Pitx2 Flox/Flox) and Pitx2 CKO
(Pitx2 Flox/Flox MCK-Cre) mice. Mean and standard deviation of R-R interval from
each mouse were listed. Two-sided, unpaired Student’s t-test was performed for mean
and standard deviation values of R-R interval; no signiﬁcant difference was detected
of mean R-R interval value between controls and mutants (p = 0.543); standard
deviation of R-R interval from mutant mice were signiﬁcantly greater than that of
control mice (p = 0.003). ms: millisecond. SD: Standard Deviation.
p = 0.543 ** p = 0.003
Animals Age # of heart beats R-R interval (ms)
Mean (*) SD (**)
Ctrl 1
2-4 months
554 105 9
Ctrl 2 392 146 10
Ctrl 3 467 123 10
Ctrl 4 447 127 10
Ctrl 5 7 months 420 142 10
CKO 1
2-4 months
488 117 30
CKO 2 408 140 24
CKO 3 420 137 21
CKO 4 485 118 18
CKO 5 505 114 16
CKO 5 585 98 29
CKO 6 7-8 months 513 113 16CKO 7 420 137 45
Table 2.2: Mice tested by telemetry ECG. The table summarizes genotype, age,
number and phenotype of mice tested by telemetry ECG.
Genotype Age # of Animals Phenotype
Pitx2 Flox/Flox 2-4 months 4 Normal sinus rhythm (4/4)
Pitx2 Flox/Flox 7-8 months 1 Normal sinus rhythm (1/1)
Pitx2 Flox/Flox 2-4 months 5 Sinus node dysfunction with im-
paired atrial conduction (5/5)
Pitx2 Flox/Flox 7-8 months 2 Sinus node dysfunction with im-
paired atrial conduction (2/2)
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Figure 2.2: Pitx2 conditional knock out mice have abnormal heart function. Sinus
node dysfunction with impaired atrial conduction were observed in Pitx2 conditional
knock out mice. By telemetry ECG tracing in awake mice, heart function of the adult
control (Pitx2 Flox/Flox) and Pitx2 CKO (Pitx2 Flox/Flox MCK-Cre) mice were tested. (A)
In control mice, normal sinus rhythm was observed. (B) In the Pitx2 CKO mice, mu-
tant heart function including irregular R-R intervals and low voltage of P waves (open
arrowheads) were observed. Tracings from one control and two Pitx2 CKO mice are
shown. All mice shown were 3-month-old. The unit of R-R interval is millisecond
(ms). Figure credit: Ye Tao
24
2.3.3 Unbiased discovery of Pitx2 regulated target genes
Weperformedmicroarray transcriptional proﬁling on 3-, 6-, and 12-week-oldwhole
hearts from Pitx2 CKO and control mice (Figure 2.4). Most genes were upregulated
in Pitx2 CKO mutant hearts, suggesting that Pitx2 is a transcriptional repressor in the
adult heart (Figure 2.3A; Figure 2.5). We performed clustering analysis on all differen-
tially expressed genes and identiﬁed 5 gene expression categories in Pitx2 CKO hearts
compared with controls. Groups I, IV, and V genes were upregulated signiﬁcantly in
the Pitx2 CKO at the 12-week stage. In contrast, group III genes were upregulated at
the 3- and 6-week stages in Pitx2 CKO hearts. Group II genes, the only gene class
that was downregulated, were reduced at 12 weeks in Pitx2 CKO hearts (Figure 2.3B).
Genes in groups I, IV, and V were involved in cell junction assembly, as well as pro-
liferation and migration (Figure 2.3C).
To investigate Pitx2 direct target genes, a ChIP-Seq assay was performed at the
12-week stage on heart tissue. Overlay of Pitx2 ChIP-Seq data and the 12-week ex-
pression proﬁling revealed genes that are likely direct Pitx2 target genes. Gene on-
tology analysis of the ChIP-Seq/microarray overlay gene-set indicated that most Pitx2
target genes are involved in cell-cell junction organization and ion channel physiology
(Figure 2.6A; Figure 2.7). Another important gene ontology term providing insight
into Pitx2-mediated arrhythmias was arrhythmogenic right ventricular cardiomyopa-
thy thought to be a desmosome defect. We categorized Pitx2 direct target genes into
4 main groups based on gene function, including cell junction assembly (group A),
ion transport (group B), arrhythmogenic right ventricular cardiomyopathy (group C),
and transcriptional regulation (group D, Figure 2.6B). Enriched ChIP-Seq tags (peaks)
were identiﬁed in potential regulatory chromosomal regions for these targets (Figure
2.9A; Figure 2.8).
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Figure 2.3: Age-related gene expression proﬁling in Pitx2 mutants. (A) Clustering
analysis of gene expression proﬁle across three time points in control and Pitx2 mutant
hearts. Expression patterns of ﬁve representative groups are shown in heat map. The
color bar represents relative expression level for each gene across different samples.
(B) Differential expression between Pitx2mutant and control across three time points.
Mean value for each group was used to calculate fold change between mutants and
controls. Box plots for selected clusters show median (middle line), third and ﬁrst
quartile (top and bottom hinges of the boxes), whiskers and outliers (black dots). (C)
Gene ontology analysis of genes in each group. GO terms related to biological process
and molecular function categories.
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Figure 2.4: Microarray intensity value distribution and reproducibility. (A) Microar-
ray was performed on Pitx2 control and mutant hearts collected from 3-, 6- and 12-
week-old mice. At each time point, three controls and three mutants were collected as
biological replicates. Raw signal values were normalized using a logarithmic method.
No signiﬁcant outlier was observed across the samples. (B) Mean of logarithmic raw
signal values of biological replicates was used for comparison between groups. No
signiﬁcant outlier was observed across groups. (C) Reproducibility of microarray raw
signal across three biological replicates in each group. Each probe was plotted using
raw signal value from one biological replicate as x-axis value, and that from another
biological replicate as y-axis value. Total 45,101 points were plotted on each diagram.
Linear correlation coefﬁcient was measured, as r given in each diagram. The blue lines
on each diagram indicate the line of best ﬁt.
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Motif analysis identiﬁed the Pitx2-binding element as the most highly enriched in
the ChIP-Seq data set validating our experiment (Figure 2.6C) [1]. Other transcription
factor binding sites were also enriched in the ChIP-Seq data set, providing further
insight into potential Pitx2 co-factors in the adult heart (Figure 2.6C). Among potential
Pitx2 cofactors, Nkx2.5 is of great interest because it has been implicated in human
AF in GWAS [100].
Our data sets indicated that other genes that have been implicated in human AF
throughGWAS or other genetic analysis are potential Pitx2 target genes such asKcnq1,
Cav1, and Zfhx3 [99, 94, 41, 50, 16, 32, 10]. Other Pitx2 target genes, such asCacna1d
and Tbx20, have also been implicated directly in AF in mouse models or other human
arrhythmias such as prolonged QRS (Table 2.3) [100, 154, 123, 7].
2.3.4 Pitx2 directly regulates genes involved in cell junction assembly, ion
transport, and transcriptional regulation
We validated gene expression changes for genes in ChIP-Seq/microarray overlay
by real-time reverse transcription PCR. We also evaluated several candidate genes,
previously implicated in human arrhythmias, that were unchanged on the microarray.
Among these were Kcnq1, Cav1, Tbx20, and Zfhx3. In Pitx2 CKO hearts, we found
increases in gene expression levels for ion channel and calcium handling genes such
as Cacna1d, Cacna2d2, Kcnq1, Kcnj11, Ryr2, Jph2, and Atp2a2. We saw upregulated
expression of genes encoding transcriptional regulators Hdac7, Tbx20, and Zfhx3, as
well as Cav1, a component of caveolae. Signiﬁcantly, elevated histone deacetylase
(Hdac) activity has been implicated in AF vulnerability, structural remodeling, and
ﬁbrosis [78]. Tbx20 is a central component of a gene regulatory network that includes
channel genes and other transcriptional regulators [118]. Zfhx3, a homeodomain zinc
ﬁnger transcription factor that was implicated in AF via GWAS, is also required for
28
Figure 2.5: Differential expressed genes in each stage. (A-C) Pitx2 controls and mu-
tants were compared to each other within each stage using linear models. Individual
genes were plotted using logarithmic of fold change as x-axis index and -log10 of p-
value as y-axis index. Total 45,101 points were plotted on each diagram. Differential
expressed genes with a fold change of at least 1.5 and p value < 0.05 were highlighted
in blue. The numbers of genes up-regulated or down-regulated in each stage were
shown as n.
Table 2.3: Genes involved in human atrial ﬁbrillation and related arrhythmias
identiﬁed by GWAS. Gene symbol, gene type and heart function involved are shown.
Gene symbol Gene type Heart function involved
Tbx5 T-box Transcription factor Atrial ﬁbrillation; PR interval
Tbx20 T-box Transcription factor QRS duration
Cav1 Caveolae protein Atrial ﬁbrillation; PR interval
Zfhx3 Zinc ﬁnger homeobox protein Atrial ﬁbrillation
Cacna1d Calcium channel voltage depen-
dent
Atrial ﬁbrillation; QRS duration
Kcnq1 Potassium voltage-gated channel Atrial ﬁbrillation; QT interval
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Figure 2.6: Overlay of Pitx2 ChIP-Seq and gene expression proﬁling assays for Pitx2
CKO heart. (A) Gene ontology (GO) analysis for genes (n=653) from overlay of Pitx2
ChIP-Seq and Pitx2 CKO microarray assays (genes in close proximity to Pitx2 bind-
ing chromosomal regions identiﬁed by Pitx2 ChIP-Seq assay that also show signiﬁ-
cant change in microarray assay for Pitx2 CKO heart). Both assays performed on
3-month-old adult mouse hearts. (B) Heat map of gene expression proﬁling obtained
by Pitx2 CKO microarray assay. The color bar represents relative expression level
of log-transformed value for each gene across different samples. Ctrl1-Ctrl3: con-
trol mouse heart (Pitx2 Flox/Flox); CKO1-CKO3: Pitx2 CKO mouse heart (Pitx2 Flox/Flox
MCK-Cre). (C) Motif analysis for peaks from Pitx2 ChIP-Seq (n=11,280). Enriched
DNA binding motifs and best matched factors are shown.
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Figure 2.7: ChIP-Seq peaks overlay with upregulated genes from microarray. (A) An-
notation of Pitx2 ChIP-Seq peaks from 12-week-old heart. Total 11,275 peaks were
detected. 18.8% of the Pitx2 ChIP-Seq peaks were located in promoter or transcrip-
tion start sites (TSS) regions; 12.1% in exons; 35.3% in intron, 32.0% in intergenic
regions and 0.1% in transcription terminal sites (TTS). (B) The density of Pitx2 mo-
tif (GCTGGGATTACA) within ChIP-Seq peaks was shown. The occurrence of Pitx2
motif was close to the center of the peaks. (C) Total 7,983 unique genes were found
by annotating closest gene to the ChIP-Seq peaks. 1,427 genes were up-regulated in
12-week-old Pitx2 mutant hearts. Overlaid 653 genes consist of 8.1% genes having
ChIP-Seq peaks and 45.7% up-regulated genes in 12-week-old Pitx2 mutants.
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Figure 2.8: Genome browser tracks for additional potential targets of Pitx2 in adult
heart identiﬁed by ChIP-Seq. Four potential targets of Pitx2 identiﬁed by ChIP-Seq
by our studies are shown here: Tbx5, Zfhx3, Ctnnb1 and Gja1. Peaks from ChIP-Seq
and conservation with human genome are shown. Normalized ChIP-Seq tag numbers
are shown on the y-axis.
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normal pituitary development as is Pitx2 [104]. Caveolins are known to associate with
channel proteins and are thought to modify channel function [144]. Our results also
revealed higher mRNA expression levels for the genes Gja1, Emd, Dsp, and Plec,
encoding ID components that are required for structural homeostasis and signaling be-
tween cardiomyocytes (Figure 2.9B). Genes that were unchanged or reduced in reverse
transcription PCR assays are listed in Table 2.4.
Based on phylogenetic conservation and Dnase I hypersensitivity, we cloned 1
to 3 kb DNA sequences ﬂanking multiple Pitx2 ChIP-Seq peaks (Figure 2.9A) into
luciferase reporters and performed transactivation experiments in cultured cells. Lu-
ciferase activity for the ChIP-Seq regions that are in close proximity toTbx20,Cacna1d,
Kcnq1, Cav1, and Emd were repressed signiﬁcantly on Pitx2 co-transfection, indicat-
ing that Pitx2 directly represses gene expression through binding to these chromosomal
regions (Figure 2.9C).
2.3.5 Pitx2 mutants have an atrial cardiomyopathy with disrupted junctional
complexes
Among the top Pitx2 target gene function categories are cell junction assembly and
arrhythmogenic right ventricular cardiomyopathy. To investigate ID status in Pitx2
CKO hearts, we used immunostaining with antibodies against β-catenin to label ad-
herens junctions in the ID. β-catenin mediates cell adhesion between cardiomyocytes
and also functions as a cell signaling molecule once activated by Wnt signaling. In
controls, β-catenin clearly marked IDs, whereas in Pitx2 CKO, there were fewer dis-
tinct IDs and more β-catenin expression on lateral aspects of cardiomyocytes (Figure
2.10A-D).
We used TEM to investigate further ID structure in Pitx2 mutants. In contrast to
controls (Figure 2.10E-G), Pitx2 mutant IDs had widened spaces between junctions,
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Table 2.4: Expression unchanged or reduced gene tested by qRT-PCR. Other gene
tested by qRT-PCR. Gene symbols and result from the experiments are shown
Gene symbols Alteration in Pitx2 CKO left atrium
Kcnn3
No signiﬁcant change
Nkx2.5
Ctnnb1
Tbx5
Dlg1
Cav2 Decreased
Figure 2.9: Validation of Pitx2 targets from ChIP-Seq and microarray assays. (A)
Genome browser tracks for potential targets of Pitx2 in adult heart identiﬁed by ChIP-
Seq. Peaks from ChIP-Seq, conservation with human genome and the chromosomal
regions used in reporter assay are shown. Normalized ChIP-Seq tag numbers are
shown on the y-axis. (B) Alteration in expression levels for the potential Pitx2 tar-
gets were detected by realtime RT-PCR in the left atrium of 3 to 4-month-old control
and Pitx2 conditional knock out mice. (n=6) (C) Reporter assay for ChIP-Seq iden-
tiﬁed potential targets of Pitx2. Chromosomal regions were named after the genes in
closest proximity. Values and error bars represent mean and standard deviation (n=6).
Figure credit: Lele Li, Ye Tao
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Figure 2.10: Pitx2 CKO mouse heart has altered expression pattern for β-catenin and
disrupted intercalated discs (IDs). (A-D) β-catenin immunostaining on left atrium sec-
tions of 3-month-old control (Pitx2 Flox/Flox) (A-B) and Pitx2 CKO (C-D) mice shows
enhanced expression of β-catenin on cardiomyocytes lateral aspect (big arrows in D)
and in cytoplasm (big arrows in C). Small arrows point to IDs. (E-J) Electron mi-
croscopy shows disrupted IDs in one-year-old Pitx2 CKO heart. (E-G) in control
left atrium, IDs (big arrows) and mitochondia were intact (triangles). (H-J) in Pitx2
CKO left atrium, some IDs were disrupted (arrowheads). Large number of mitochon-
dria were deteriorated (asterisks). Indistinct Z-lines were observed in Pitx2 CKO left
atrium (small arrows). Figure credit: Ye Tao
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indicating ID deterioration (Figure 2.10H-J). We also found evidence for mitochon-
drial dysfunction with swollen and vacuolated mitochondria in Pitx2CKO hearts (Fig-
ure 2.10H-J). Pitx2 CKO cardiomyocytes also had indistinct Z-lines, indicating that
Pitx2 is required for maintaining normal sarcomere cytoarchitecture (Figure 2.10H-J).
2.4 Discussion
Pitx2 is the gene in proximity to the 4q25 familial AF locus. Previous work indi-
cated that reduced Pitx2 levels result in AF predisposition. Before our experiments,
it was unknown whether Pitx2 was important in postnatal heart because previously
reported adult phenotypes could result from developmental defects. In addition to un-
covering a Pitx2 postnatal function, our ﬁndings reveal novel Pitx2 target genes and
that Pitx2 is required for ID homeostasis in postnatal atrium (Figure 2.11).
2.4.1 Pitx2 postnatal deletion results in sinus node dysfunction
Pitx2 deletion in postnatal atrium caused resting atrial arrhythmias, indicating that
in addition to its developmental function, Pitx2 has a genetically separable postna-
tal function in left atrial homeostasis. The predominant arrhythmia we observe with
resting telemetry is SND, which is known to be clinically linked to AF in human pa-
tients. SND can result from defective impulse generation from the sinus node. In
addition, SND similar to AF is associated with diffuse atrial remodeling, resulting in
an arrhythmogenic substrate. Consistent with this, we observe anatomic disruption of
cardiomyocyte junctions in Pitx2 CKO hearts [69].
The Pitx2c+/- mice that have a 37% reduction in Pitx2c levels have no structural
abnormalities or obvious histological defects but are still prone to AF [63]. Molecular
analysis indicates that Pitx2c+/- mice have electric remodeling with changes in chan-
nel gene expression. The authors also noted changes in desmosomal genes, such as
Dsg2, raising the possibility that Pitx2c+/- mice may also be prone to structural remod-
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Figure 2.11: Model of Pitx2’s function in postnatal heart. In postnatal heart, Pitx2
binds to its targets through DNA binding domain and regulates expression of targets.
Three groups of genes were identiﬁed to be targets of Pitx2. The ﬁrst group contains
genes regulating cell adhesion/cell junction assembly, which is critical for preserving
normal structure of ID. The second group contains genes that regulate ion transporta-
tion in and between cardiomyocytes, which are important for normal conduction of
electrical signal that induces heart contraction. The third group contains transcription
regulators that regulate a large number of downstream targets and involved in regulat-
ing cardiac function and maintaining homeostasis of cardiomyocytes.
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eling. Taken together with previous studies, our ﬁndings reveal that Pitx2 has both
developmental and postnatal functions that predispose the heart to atrial arrhythmias.
2.4.2 Pitx2 regulates intercalated disc maturation and homeostasis
Our array data reveal that major changes in gene expression were detected at 12
weeks of age. Moreover, ChIP-Seq data support the model that Pitx2 directly regu-
lates genes involved in ID homeostasis. Structural remodeling of intercellular connec-
tions and an increase in ﬁbrosis represent known anatomic substrates for AF. Notably,
Pitx2 mutants have upregulated expression of ID genes, suggesting that the correct
stoichiometry of ID component genes is important to maintain ID structure. The im-
munoﬂuorescence showing β-catenin mis-localization and TEM revealing breakdown
of intercellular junctions also strongly support the notion that Pitx2 is required for ID
maturation and homeostasis.
In the developing and postnatal heart, ID components including desmosomes, gap
junctions, and adherens junctions are initially expressed in a dispersed pattern. As
the heart matures, ID components become localized into the ID at the cardiomyocyte
termini [5]. At the transcriptional level, expression of genes such as Emd and Gja1
is reduced as the heart matures [136, 119]. Intriguingly, emerin (Emd) is known to
function as a β-catenin-interacting protein that also modulates β-catenin intracellular
localization [143]. It is conceivable that lateralized β-catenin that we observe in the
Pitx2 mutant left atrium may be because of elevated Emd levels. Together, our data
indicate that Pitx2 is required for this transcriptional downregulation of ID component
genes in left atrium myocardium.
Our ﬁndings have implications for AF progression to chronicAF. The severe anatomic
abnormalities observed in Pitx2 CKO hearts suggest that these are irreversible struc-
tural defects. Moreover, the TEM data suggest that the Pitx2 CKO hearts have dete-
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riorating mitochondria, suggesting cellular compromise further supporting the notion
that Pitx2 CKO arrhythmias are irreversible. The TEM data also revealed that Pitx2
CKO atrial cardiomyocytes had Z-line defects, suggesting that Pitx2 also regulates
sarcomere homeostasis. Interestingly, we previously observed formation of M-lines
and more mature sarcomeric structure in Pitx2 CKO extraocular muscle, which nor-
mally lacks M-lines, suggesting context-dependent functions for Pitx2 in sarcomere
regulation [157].
2.4.3 Pitx2 and ion current regulation
Our data support previous observations that multiple genes involved in calcium
handling and potassium channels are changed in Pitx2 mutants [63]. The ChIP-Seq
data indicate that multiple genes that compose the calcium release unit such as Ryr2,
Jph2, and Atp2a2 are regulated directly by Pitx2 [28]. Genes involved in calcium
homeostasis have been implicated in both AF initiation and progression to chronic AF
[122]. For example, Ca2+/calmodulin-dependent protein kinase II has been shown to
phosphorylate the ryanodine receptor 2 at S2814, resulting in incomplete ryanodine
receptor 2 closure with calcium leak. Increased phosphorylation of ryanodine recep-
tor 2 has been demonstrated in human patients with chronic AF, as well as other AF
models [15, 29]. Our ChIP-Seq/microarray data sets indicate that RyR2 is upregulated
in Pitx2 mutant adult hearts, suggesting that in addition to phosphorylation, transcrip-
tional regulation may be a regulatory node for modulating calcium handling in atrial
cardiomyocytes.
In Pitx2 CKO postnatal hearts, the inward rectiﬁer Kcnj11 was both directly bound
by Pitx2 and upregulated at the mRNA level, a likely AF risk factor [60]. This upregu-
lation is consistent with the shortened action potential duration that has been described
previously in Pitx2 mutants [19, 63].
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2.4.4 Pitx2 and AF in the developing and postnatal heart
Our ﬁndings suggest that postnatal atrial cardiomyocytes require persistent Pitx2
expression for ID homeostasis and maturation. Pitx2 regulates separate mechanisms,
a developmental mechanism and a postnatal homeostatic mechanism, that result in an
arrhythmogenic substrate. This is also reﬂected in the expression dynamics of Pitx2
target genes in the developmental and postnatal contexts. Scn5a and Kcnj10 are down-
regulated in Pitx2mutant atrium during development but upregulated in postnatal mu-
tants [19]. One explanation for this is that Pitx2 may have separate cofactors at devel-
opmental and postnatal stages that result in distinct transcriptional readouts.
Our ﬁndings also have implications for human AF. Previous GWAS implicated
multiple genes as potential contributors to the pathogenesis of human AF and pro-
longed PR interval [84]. Our Pitx2 ChIP-Seq data identiﬁed several of these genes as
potential Pitx2 target genes in postnatal hearts (Table 2.2 [84, 100]. Because Pitx2 reg-
ulates many of these genes in the postnatal and adult heart, it is conceivable that drugs
can be developed to modulate the molecular interaction between Pitx2 and its target
genes. Because fetal therapies currently lack feasibility, our ﬁndings that many im-
portant Pitx2-regulated events occur postnatally strengthens the likelihood that Pitx2-
mediated AF may be treatable in the future.
2.5 Materials and methods
2.5.1 Mouse alleles and transgenic lines
TheMCK-Cre transgenic line,R26R transgenic line,Pitx2 conditional null or ﬂoxed
allele and Flag knock in allele have been described [138, 156]. The Pitx2 conditional
null allele contains LoxP sites ﬂanking the exon encoding the N-terminus of home-
odomain and conditionally removes function of all Pitx2 isoforms.
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2.5.2 Telemetry ECG
Implantation of the telemetry transmitter ETA-F10 (Data Sciences International)
was done following the protocol of the manufacturer. Transmitters were placed in-
traperitoneally and ECG leads were at a lead II conﬁguration. ECG data was collected
by DSI Telemetric Physiological Monitor System and processed by Dataquest A.R.T.
3.1 software (Data Sciences International) without stress from restraint or anesthesia.
2.5.3 ChIP-Sequencing
Chromatin immunoprecipitation was performed as described previously using EZ
ChIPTM kit (Millipore) and Anti-FLAG M2 Afﬁnity Gel (Sigma) . For library con-
struction, 10-50 ng of puriﬁed ChIP DNA was end-repaired using Ion Plus Fragment
Library Kit (Part no. 4471252, Life Technologies) and puriﬁed with two rounds of
AMPure XP beads (Beckman Coulter, Brea, CA) capture to size select fragments 100-
250 bp in length. End-repaired DNA was ligated to Ion Torrent compatible adapters.
Followed by 15 cycles of PCR ampliﬁcation before downstream template preparation.
DNA fragments of completed library ranged from approximately 170-220 bp in length.
Sequencing was performed on Ion Torrent PGM system (Life Technologies).
2.5.4 Statistical analysis
Microarray raw data were generated using Affymetrix MAS5.0, global scaling was
performed to set mean target intensity to 100. The normality of themicroarray data was
checked using quantile-quantile plot and Shapiro-Wilk test on R (3.0.1). Differential
expressed genes were detected using R package limma (3.16.8) [121] with threshold
p-value  0:05 and fold change  1:5. Benjamini-Hochberg correction was used to
calculate false discovery rate. All the differential expressed genes have FDR < 0.35.
Clusters were automatically detected using R package HOPACH (2.20.0) [101]. The
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distance matrix was calculated using cosine angle method. Over-represented gene on-
tology terms were identiﬁed using GO-Elite [152] with Z score> 3, FDR< 0:10. FDR
was calculated using Benjamini-Hochberg correction after permutation (n = 5000).
qRT-PCR and luciferase reporter assay results were tested using two-sampleWilcoxon
test in R. Difference of R-R interval between wild type and mutant mice was tested us-
ing two-tailed, unpaired Student’s t-test using R (n> 400). ChIP-Seq peaks were iden-
tiﬁed using Homer [49] under the assumption that the local density of the reads follow
an Poisson distribution. The peaks were called using cutoff: read number enrichment
 4 folds, FDR < 0:001, FDR effective Poisson p-value < 3.7e-8, and minimum read
number 5.
2.5.5 β-Gal staining and immunostaining
β-Gal staining was done as previously described [138]. Immunostainings were
done on frozen sections of adult heart. Samples were incubated in primary antibody
at 4C overnight. After washing in PBS, sections were incubated in the appropri-
ate ﬂuorescent-labeled secondary antibodies, followed by counterstaining with DAPI
(Sigma) then mounted in Vectashield H-1000 mouting medium (Vector Laborataries,
Inc.). Primary antibodies used were as follows: Rabbit polyclonal anti-Pitx2 (1:100)
(Capra Science) and Rabbit anti-β-catenin (1:100) (Cell Signaling). Secondary anti-
bodies used was as follows: Alexa Fluor 488 goat anti-rabbit IgG (1:1000) (Molecu-
lar Probes). Immunoﬂuorescent images were captured on a Leica TCS SP5 confocal
microscope, and all functions were controlled via Leica LAS AF software (Leica Mi-
crosystems).
2.5.6 Realtime RT-PCR and luciferase assay
Total RNAwas isolated using the miRNeasy mini Kit (QIAGEN), followed by RT-
PCR using qScriptTM cDNA SuperMix (Quanta Biosciences). Three biological repli-
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cates were collected for control and mutant. Real-time thermal cycling was performed
using Stepone Plus thermal cycler (Applied Biosystems) with SYBR Green (Quanta
Biosciences). Comparative Ct method was used to quantitate relative gene expres-
sions. Firstly, Ct value of both mutants and controls was normalized to an endogenous
housekeeping gene (GAPDH). Secondly, each sample was calibrated to the mean of
control Ct value. Lastly, Ct value was transformed to fold change using exponential
transformation. Standard deviation of both control andmutant sampleswere calculated
within the groups. Two-sampleWilcoxon test was performed between control and mu-
tant. Sequences of PCR primers are available upon request. Luciferase reporters were
constructed from PGL3 luciferase reporter vector (Promega) and 1-3 kb DNA frag-
ment ampliﬁed from Genomic DNA using primers for ChIP-Seq peak regions. PCR
was performed using PrimeSTAR HS DNA Polymerase (Takara Biotechnology Co.,
LTD.). Clonings were done by using Gateway Vector Conversion System (Invitro-
gen). Sequences for PCR primers are available upon request. Expression contruct for
Pitx2c was obtained from Dr. Brad Amendt. 293FT cells were transfected with the re-
porter construct and Pitx2c expression construct or control construct.Transfection was
done by using Lipofectamine 2000 (Invitrogene) per the manufacturer’s protocol. Lu-
ciferase activities were measured on Inﬁnite M200 Pro multimode microplate reader
(TECAN) using Dual-Glo Luciferase Assay System (Promega) per the instruction of
the manufacturer. Average luciferase activity are reported with standard deviation.
Two-sample Wilcoxon-test was performed using R.
2.5.7 R-R interval measurement
Telemetry ECG data was collected on DSI Telemetric Physiological Monitor Sys-
tem and processed by Dataquest A.R.T. 3.1 software (Data Sciences International).
For each mouse, manually select uninterrupted one miniute ECG interval with uni-
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form maximum R-wave voltage; number of heart beats counted accordingly. R-R
intervals were measured in the unit of millisecond. Mean and standard deviation of
R-R interval from each mouse were calculated using R software. Two-tailed, unpaired
Student’s t-test (n > 400) was performed for mean and standard deviation values of R-
R interval; no signiﬁcant difference was detected of mean R-R interval value between
controls and mutants (p = 0.54); standard deviation of R-R interval from mutant mice
were signiﬁcantly greater than that of control mice (p = 0.003).
2.5.8 Microarray and ChIP-Seq data processing
Pitx2 control and mutant hearts were collected from 3-, 6- and 12-week-old mice.
At each time point, three controls and three mutants were collected as biological repli-
cates. cDNA microarray analysis was performed using Affymetrix GeneChip Mouse
Genome 430 2.0 Array (Affymetrix, Santa Clara, CA). The raw data of microarray was
generated using Affymetrix Microarray Suite version 5.0 (MAS 5.0) using Affymetrix
default analysis settings and global scaling as a normalization method. The trimmed
mean target intensity of each array was arbitrarily set to 100. The value distribution
of raw intensity from total 18 samples was graphically viewed in box plots. To show
reproducibility across three biological replicates within each group, linear correlation
coefﬁcient value r was measured between each pair of replicates within each groups
using R software function var.
Differential expressed genes were detected using R bioconductor package Limma
version 3.16.8. Brieﬂy, log transformation was performed to the raw intensity values,
the normality was checked using histogram and quantile-quantile plot for each con-
dition; Shapiro-Wilk test was performed on randomly selected 300 genes from each
array using R shapiro test function, resulted p value > 0.05 for all 18 individual chips.
Student’s t-test was performed to identify differences of expression level between wild
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type and mutants for each probe. Benjamini & Hochberg false discovery rate method
was used for multiple comparsion correction. Differentially expressed genes were
called using cutoffs p-value ≤ 0.05; fold change ≥ 1.5 and FDR ≤ 0.35.
We compared differential expressed genes in 3-, 6- and 12-week of age individu-
ally. Total 3,323 genes were collectively called as differentially expressed, and were
subjected to R packageHOPACH to perform unsupervised clustering based on a cosine
angle distance matrix. The ﬁrst level of the hierarchical tree contains 5 clusters, one of
which has 2,697 genes with signiﬁcant higher expression value compared to the other
4 clusters. Gene ontology analysis showed that genes from this cluster are enriched in
heart and atrium. Clusters I-V, shown in Figure 2.3, were clusters on the third level of
the tree derived from this highly expressed, heart-related gene group, with a minimum
of 30 genes in each cluster. Raw intensity values from individual samples were used
to plot in heat map. Relative expression value was calculated using following formula
and illustrated in color:
Relative expression value = Individual expression density meanstandard deviation (2.1)
Over-represented gene ontology terms were identiﬁed using GO Elite with its de-
fault Z score and permutation methods. To calculate Z score, the observed number of
genes in the input gene list was subtracted from the expected number of genes asso-
ciated with a particular biological term and divided by the standard deviation of the
observed number. To determine the likelihood of observing the calculated Z score by
chance, the permutation analysis was performed. The same number of genes as input
gene list was randomly selected from background gene list and calculated Z score.
This process was repeated 5000 times for each input gene list. False discovery rate
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was calculated using Benjamini-Hochberg correction. GO terms were plotted using Z
score (Figure 2.6A). Only terms with FDR < 0.10 were reported.
Ion torrent PGM reads were mapped to the mm9 assembly (NCBI Build 37) using
Torrent Suite (2.0.1) aligner Tmap (0.2.3) (Life Technologies). The ChIP-Seq sig-
nal was normalized to a 10 million reads total and visualized in the UCSC genome
browser. ChIP enriched peaks were identiﬁed using Homer 4 by the default setting.
Brieﬂy, a ﬁxed peak size was calculated automatically, in our case, the peak size was
162 bp. The program then scanned the entire genome for 162 bp clusters with the
highest density of reads. After all clusters have been found, the program compared
Pitx2 ChIP-Seq reads against input control reads. The cutoffs for calling the peaks
were read number enriched at least 4 fold, FDR threshold 0.001, FDR effective Pois-
son p-value 3.7e-8, and minimum read number 5. This process produced 11,280 en-
riched peaks. Nearest genes associated to the enriched peaks were annotated using the
annotatePeaks function and de novo motif discovery was performed using the ﬁnd-
MotifsGenome function in Homer. Genes associated to ChIP-Seq peaks were overlaid
with signiﬁcantly up-regulated genes in 12-week mutants. The overlaid gene list was
analyzed with GO Elite for enriched gene ontology terms. Microarray and ChIP-Seq
data are available through the NCBI Gene Expression Omnibus (GEO) data repository
under accession GSE50401.
46
3. LONG-RANGE INTERACTIONS BETWEEN PITX2 AND HIGH-RISK LOCI
OF ATRIAL FIBRILLATION
Human 4q25 region is highly associated with risk of familial atrial ﬁbrillation (AF),
with multiple single nucleotide polymorphisms (SNPs) at this locus. The region was
ﬁrst identiﬁed from a genome-wide association study (GWAS) performed in an Ice-
landic population [41]. Multiple subsequent studies have consistently demonstrated
a robust association between this locus and AF [84]. The AF-associated SNPs at
the 4q25 locus are located in an gene-desert sized about 1.5 million base pairs. The
closest gene is the paired-like homeodomain transcription factor 2 (PITX2). Previ-
ous work indicates haploinsufﬁciency of Pitx2 promotes an arrhythmogenic pheno-
type in mice[138]. Moreover, as described in the previous section, Pitx2 has its in-
dependent role in postnatal stage, regulating genes encoding cell junction proteins,
ion channels, and critical transcriptional regulators. Importantly, many of these Pitx2
targets have been implicated in human AF. However, the direct connection between
non-coding 4q25 locus and PITX2is unclear. It is unknown whether the high-risk loci
are regulatory elements that directly control the expression of Pitx2 via physical inter-
action; whether these regulatory elements alters developmental programs or triggered
by environmental factors during adulthood, and whether up-stream signals, such as
arrhythmia-induced cardiac stress, regulate Pitx2 expression through modifying topol-
ogy of three-dimensional (3D) chromosome structure.
3D chromosome structure of the genome is known to play an important role in
transcriptional control of genes for decades [22]. But not until recently, develop-
ment of chromosome conformation capture (3C) technology [25] advanced our un-
derstanding of regulatory interactions in a three-dimensional setting. Coupled with
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high-throughput sequencing, the technology now allows the assessment of one-to-all
(4C), many-to-many (5C) or all-to-all (Hi-C) [23, 24] interactions. Moreover, meth-
ods such as ChIA-PET allows assessment of all loci bound by a speciﬁc protein ([36]).
High resolution Hi-C results reveal the genome-wide organization of topologically
associated domains (TADs) [73, 108]. TADs [27, 95, 117, 23] are deﬁned as chromo-
somal regions that sequences are preferentially contact each other. The median size
of TADs is 185 kb, but varies from 40 kb to 3Mb. The boundaries between TADs
are highly associated with sites bound by CCCTC-binding factor (CTCF) [108], as
well as cohesin complex. Here, we describe 4q25 is located in the same TAD with
Pitx2 which is located close to the boundary of the TAD. Bioinformatic analysis iden-
tiﬁed heart-speciﬁc enhancer activity overlaid with AF risk loci. 4C-Seq result suggest
a direct interaction between the enhancer peaks and Pitx2aband Pitx2cpromoters, as
well as a downstream gene encoding a glutamyl aminopeptidase (Enpep). Knocking-
out these enhancers using CRISPR/Cas9, Pitx2ab expression signiﬁcantly reduced in
vivo. Furthermore, deletion of CTCF binding sites reduce the expression of Pitx2ab,
Pitx2c and Enpep. Our ﬁndings, revealing a direct interaction between Pitx2 and AF
high-risk locus, unveils a potential regulatory functions of non-coding variations in
atrial ﬁbrillation.
3.1 Results
3.1.1 Pitx2 is located on the topologically associated domain boundary
Human 4q25 AF associated gene desert region is highly conserved with mouse a
1 Mb block in mouse chromosome 3, both in DNA sequence and genome organiza-
tion levels. Within this 1.5 Mb genome block, Pitx2 and its neighboring genes are
located by the same order and orientation. More over, high resolution Hi-C [108]
and CTCF ChIP-Seq [33] datasets across different tissue revealed striking similarity
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of TAD structure between human and mouse tissue (Figure 3.1), which most of then
4q25 gene desert region is located in one TAD, while Pitx2 and its neighbor Enpepare
located on the boundary of the TAD. CTCF binding sites are found in both Pitx2 and
Enpep gene bodies, as well as in-between these two genes. Interestingly, a CTCF
binding peak separates two individual promoters of Pitx2 isoforms, namely Pitx2ab
promoter and Pitx2c promoter. ChIA-PET dataset of a cohesin complex protein [30],
Sma1, revealed long-distance interactions between Pitx2 promoters and regions in the
same TAD, as well as local interaction between themselves (Figure 3.1A&D). Further-
more, indicated by histone marks ChIP-Seq datasets [33], Pitx2 expression is active,
whereas Enpepexpression is poised in mouse ESC. Accordingly, interaction activity
within Pitx2 gene body is much higher than within Enpep[30], suggesting a correlation
between transcription activity and chromatin organization.
3.1.2 Pitx2 up-stream regulatory region functions as an enhancer
SNPs that highly associated with AF are located 150 kb upstream of PITX2, span
within a 100 kb window (Figure 3.2). To address whether this region has potential
regulatory function, we aligned the DHS-Seq datasets across different tissues [110],
and found that clusters of DHS activity in this region. Interestingly, two sets of these
peaks are consistently observed in multiple fetal hearts, but not in other tissues, or in
adult hearts (Figure 3.2A). Since DHS marks open chromosomal region in general,
we aligned DHS genomic tracks with H3K4me1 ChIP-Seq tracks, which mark en-
hancer activity, and found that these heart-speciﬁc DHS peaks are overlaid with heart
H3K4me1 peaks, indicating potential enhancer activity. Furthermore, using a wider
range of markers, an integrative algorithm predicts the enhancer activity in this region
[110]. Although these enhancer activity are limited in fetal hearts, another enhancer
proﬁling dataset showed abnormal enhancer activity in this region from an adult donor
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Figure 3.1: Conservation of topologically associated domains (TADs). (A) CTCF
ChIP-Seq and Smc1 ChIA-PET in mouse tissue showed Pitx2 and Enpep are on the
boundary between TADs. (B, C) TAD structure in human 4q25 region is conserved
between human and mouse. (D) Local region of mouse Pitx2 and Enpep. CTCF is
associated with segregation between TADs. Additionally, chromatin activity is asso-
ciated with chromatin interaction, which is indicated by Smc1 ChIA-PET.
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with coronary artery disease (Figure 3.2A), suggesting this region can be potentially
reactivated during disease state. Noticeably, individual SNPs do not exactly overlay
with these enhancer peaks. Nonetheless, we pinpoint this 100 kb window contained
multiple SNPs associated with AF risk is a heart-speciﬁc regulatory element that has
enhancer activity.
To address whether we can study the function of this regulatory element in a mouse
model, we compared DNA sequence conservation between human and mouse genome
and found that regulatory elements that marked by DHS and enhancer marks are highly
conserved despite that their surrounding non-coding sequences have poor alignment
(Figure 3.2C).We located themouse sequences corresponding to humanAF-associated
enhancers and found that the region is marked by H3K27ac in mouse heart across dif-
ferent developmental stages [96] (Figure 3.2D). Moreover, we performed motif en-
richment analysis using enhancer DNA sequences from both human and mouse, and
found consensus binding sites of Pitx2, Hnf4a, Nrf2, Ets and Nkx factors are signiﬁ-
cantly enriched (Figure 3.2E).
3.1.3 Direct interaction between enhancer and Pitx2 promoter
To addresswhetherPitx2 promoter directly regulated by upstream enhancers through
long-range interaction. We dissected postnatal day 8 (P8) mouse hearts and performed
4C-Seq. Sequences that physically interact with each other are ligated together and
form circular DNA. To proﬁle all the sequences that interact with our regions of inter-
est, or view points, we used inverse PCR to ampliﬁed blind sequences that in the same
circular DNA molecule with Pitx2ab promoter, Pitx2c promoter, Enpep promoter, and
upstream enhancers (Figure 3.3A). The PCR products were then barcoded and sub-
jected to sequencing on Ion Proton platform. We collected total 30 million reads from
10 different view points. For individual reads, we subtract sequences from viewpoints
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Figure 3.2: Atrial ﬁbrillation associated region is overlaid with heart speciﬁc en-
hancers. (A) DnaseI Hypersensitivity Sites (DHS) shows human fetal heart speciﬁc
region is located upstream of Pitx2. H3K4me1 ChIP-Seq and chromatin HMM anal-
ysis indicates enhancer activity in these regions. (B) Heart H3K27ac ChIP-Seq from
donor with coronary artery disease show altered peaks in the upstream region of Pitx2
and downstream of Enpep. (C) Conservation alignments of DHS regions (light blue)
and enhancers (red) between human and mouse genome. (D) Mouse heart H3K27ac
ChIP-Seq tracks indicate conserved region of atrial ﬁbrillation associated enhancers.
(E) Enriched motifs present in the enhancer region.
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and map them against mouse genome, and quantiﬁed reads that are ligated to each
view point. Since each cell has only two copies of the chromatin, the amount of such
read count reﬂects an averaged picture of contact frequencies between loci in vivo. Im-
portantly, such read count is also a function of distance between loci [124]. Sequences
that are proximal to each other are more likely to be cross-linked and ligated together.
Using a linear regression model [37], we detected signiﬁcantly enriched regions that
directly contact with the view points. The AF-associated enhancer directly binds to
Pitx2ab, Pitx2c and Enpep promoters, as well as the CTCF binding site in-between
Pitx2 and Enpep (Figure 3.3B). Furthermore, we repeat the 4C-Seq experiment in an
embryo-derived teratocarcinoma cell line (P19), and found similar interaction existed.
To further investigate whether these AF-associated enhancers controls Pitx2 ex-
pression. We deleted a 20 kb region that contains two H3K27ac peaks and conserved
with human heart-speciﬁc enhancers via CRISPR/Cas9 system 3.3A). Two individual
guide RNAs are designed two create double strand DNA breaks spontaneously and
cause the deletion of large DNA fragments. We gained seven homozygous mutant
cell lines and tested gene expression level of Pitx2ab, Pitx2c and Enpep using qPCR.
Upon enhancer deletion, Pitx2ab expression is signiﬁcantly reduced across all seven
individual mutant lines by over 90%, whereas Pitx2c and Enpep expression do not
show signiﬁcant change in average (Figure 3.3C). However, the expression level of
Enpep varies between different mutant lines (Figure 3.3C).
3.1.4 Enhancer-promoter interaction is mediated by CTCF
The deletion of upstream enhancers lead to signiﬁcant reduction of Pitx2ab expres-
sion level, but not Pitx2c, suggesting a strong segregation between these two promot-
ers. Known to be genome insulators, enriched CTCF binding sites are observed inside
Pitx2 gene body, separating two promoters of Pitx2 isoforms. 4C-Seq results also sug-
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Figure 3.3: CRISPR mediated enhancer deletion. (A) Two guide RNAs are used to
target 20 kb of enhancer region, which is located 191 kb upstream of Pitx2ab promoter.
We obtained four females and one male mouse lines; and seven P19 homozygous cell
lines. (B) High-throughput chromatin conformation sequencing (4C) indicates direct
interaction between targeted enhancer and Pitx2ab, Pitx2c promoter and CTCF sites.
(C) Individual gene expression of Pitx2ab, Pitx2c and Enpep are quantiﬁed in homozy-
gous P19 cell lines using qPCR. Pitx2ab is signiﬁcantly down regulated by the deletion
of the enhancer. Pitx2c and Enpep show varied expression level among individual mu-
tant cell lines.
gest direct interaction between Pitx2 promoters and downstream CTCF binding sites.
We therefore deleted six of these CTCF sites in P19 cells to address whether the reg-
ulatory function of Pitx2 upstream enhancer is mediated by any of these CTCF sites
(Figure 3.4A&B). We found that deletion of CTCF site in-between Pitx2ab and Pitx2c
promoter (del 2, Figure 3.4A&B) increases Pitx2ab expression and decreases Enpep
expression; whereas deletion of CTCF site downstream of Enpep leads to decreased
gene expression of Pitx2ab, Pitx2c and Enpep. Furthermore, we deleted CTCF site
that segregate Pitx2ab and Pitx2c promoters (del 2) in enhancer-deleted mutant cell
lines, and found that the deletion of CTCF restored Pitx2ab expression level (Figure
3.4D).
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Figure 3.4: CRISPR mediated CTCF sites deletion. (A, B) Targeted CTCF peaks in-
dicated by heart CTCF ChIP-Seq. (C) Gene expression level in mutants of del 2 and
del 5. (D) Enhancer / CTCF del 2 double mutants are created using homozygous en-
hancer mutant line. The deletion of CTCF that segregates Pitx2ab and Pitx2c shows
rescue of Pitx2ab level in double mutants. (E) Proposed models show the hypothe-
sis that CTCF controls the speciﬁcity of promoter-enhancer interaction. The deletion
of CTCF binding sites resets promoter-enhancer looping interaction and destabilizes
neighboring looping structures.
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3.2 Discussion
Functional analysis of high-risk non-coding variations identiﬁed by GWAS is crit-
ical for understanding the cause of diseases. In this study, we identiﬁed AF-associated
region is heart-speciﬁc enhancer and directly interact with PITX2. Depletion of the en-
hancer region speciﬁcally reduced gene expression of Pitx2ab, and potentially destabi-
lized 3D genome structure. The speciﬁcity between promoter and enhancer ismediated
by genome insulator CTCF protein.
3.2.1 Dynamic of human 4q25 region
Genetic variants on human chromosome 4q25 is highly associated with AF bymul-
tiple studies [84]. The most signiﬁcant SNP, rs2200733, has an odds ratio of 1.9 for the
risk allele [57]. Large scale replication study revised 4q25 region and found two addi-
tional susceptibility signals marked by rs17579669 and rs3853445 [83]. These SNPs
are conﬁned to a 30 kb region and 50 kb away from rs2200733 3.2. Aligned with ge-
nomic tracks of DHS and H3K4me1 ChIP-Seq, we identiﬁed heart-speciﬁc enhancer
activity in this region. Curiously, although these SNPs are close to enhancer peaks
identiﬁed by histone marks, they are not perfectly overlaid. For examples, rs17570669
mismatched with a conserved skeletal-muscle-speciﬁc DHS site by 500 bp; rs2200733
is about 5 kb away from closest DHS peak. In some cases, disease-associated vari-
ations are located within TF binding motif sequences, which lead to allele-speciﬁc
TF binding. For example, in ventricle histone 3 lysine 27 acetylation bias towards
the G allele against A on rs138143205 locus [70]. In fact, an integrative analysis
on haplotype-type-speciﬁc epigenome showed 11% (n = 11,714) of all enhancers, are
allelic [70] Many of these alleles are disease-associated SNPs identiﬁed by GWAS
and their function can be tested experimentally in detail. On the other hand, our data
indicated a ”multiple enhancer variant” hypothesis, where several variants in linage
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disequilibrium impact enhancers and gene expression synergistically [21].
3.2.2 Tissue speciﬁc promoter-enhancer pairing
Tissue-speciﬁc gene expression pattern is determined by abundance of TFs and
their interaction with regulatory elements. Pitx2ab, Pitx2c and Enpephave different
expression level across different tissues (Figure 3.5A). For example, in embryonic
brain and limb, all three transcripts have relative high expression level; in adult heart,
liver and small intestine, Pitx2ab has very little expression. To address whether tissue-
speciﬁc enhancer activity correlates with tissue-speciﬁc gene expression in this AF
high-risk region. We ﬁrstly separated the 200 kb by CTCF binding sites, resulted in
two distinct groups: group one including adult small intestine, adult liver and embry-
onic liver, contains two segregated blocks, marked by CTCF site on Pitx2 gene body;
whereas group two including kidney, heart, limb and brain, contains three blocks, of
which the third block was created by CTCF sites in-between Pitx2 and Enpep (Fig-
ure 3.5B). We then quantiﬁed H3K4me1 intensity in all of the open chromosome, and
found a visible correlation between the intensity of the enhancers within the block and
the transcription activity of the promoter within the same block. When upstream en-
hancer were deleted, we found that Pitx2ab expression in P19 cells was diminished.
However, deletion of CTCF site that segregate Pitx2ab and Pitx2c promoters restored
Pitx2ab expression, supporting the hypothesis that CTCF segregates genome into reg-
ulatory blocks. Individual block dominates the enhancer-promoter speciﬁcity (Figure
3.5C&D).
3.2.3 Potential relevance to AF
We found that AF-associated enhancer speciﬁcally regulates Pitx2ab, not Pitx2c in
vitro. Curiously, Pitx2c is the dominant isoform that expressed higher level throughout
developmental stages in heart [138]. Whether Pitx2ab expression is elevated in AF
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Figure 3.5: Tissue speciﬁc promoter-enhancer interactions of Pitx2ab, Pitx2c and En-
pep. (A) Gene expression levels of Pitx2ab, Pitx2c and Enpep in different tissues. (B)
CTCF and H3K4me1 ChIP-Seq in different tissues. Regulatory regions were segre-
gated by CTCF peaks. For each section, the enhancer activity indicated by H3K4me1
ChIP-Seq intensity is associated with transcription activity. (C) Proposed model for
promoter-enhancer speciﬁcity in tissues with CTCF peaks between Pitx2c and Enpep
(e.g. kidney, heart, limb and brain); and (D) Pitx2c and Enpep share the same regula-
tory section (e.g. liver and small intestine).
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Table 3.1: Primers for genotyping of CRISPR-mediated enhancer deletion.
id Sequences
1f TTTCTCTTTTGTCACGACTGTAAAGAACAG
1r AAGTCCATAAGACACACTGAAAACATCTGA
2f CAAAGATCTTCTTTCCCTATGTTGTGTGTA
2r TTGGCATAGACTGAGTAGCATCAAGTTAAA
patients is unclear. On the other hand, reactive-oxygen species (ROS) is accumulated
in chronicle AF patients [116]. Interestingly, motif analysis of enhancer sequences
showed enrichment of consensus binding sites ofMafK and Nrf2, which are known to
be activated and shuttled into nucleus upon ROS accumulation [128]. Thus Pitx2ab
can potentially be activated by cis-regulation of MafK and Nrf2 via accumulation of
ROS in AF condition.
3.3 Materials and methods
3.3.1 CRISPR-mediated deletion
Two guideRNAs, ﬂanking a 20 kb genomic region, were designed (left: 5’- gtatttcatc-
taaggcaca; right: 5’-gatggtcacagtcaatgtg) and were cloned into PX458 vector [107] via
golden gate approach. P19 cells were transfected using Lipofectmine 2000 for 24 hrs.
Single GFP-positive cells were sorted into 96-well plates and cultured in 10%FBS α-
MEM media for seven days. Single clones were then genotyped by using two sets of
primers (Table 3.1). Mutant clones were kept for further gene expression analysis.
3.3.2 Chromatin conformation capture sequencing
Detailed protocol of 4C-Seq will be described in 4.3.15. The selected viewpoints
are show in (Table 3.2).
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Table 3.2: Viewpoints used in 4C-Seq of Pitx2 promoters and regulatory regions.
chr Start End Description
chr3 128903853 128904369 Pitx2ab promoter
chr3 128899347 128899765 Pitx2ab promoter
chr3 128916217 128917025 Pitx2c promoter
chr3 128915525 128916111 Pitx2c promoter
chr3 128867595 128868003 Pitx2 upstream enhancer
chr3 128832771 128833376 Pitx2 upstream enhancer
chr3 128834733 128835424 Pitx2 upstream enhancer
chr3 128873046 128873601 Pitx2 upstream enhancer
chr3 128959106 128959662 Pitx2 downstream enhancer
chr3 128222094 128222567 Pitx2 upstream enhancer
chr3 128222078 128222521 Pitx2 upstream enhancer
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4. ACTIN CYTOSKELETAL REMODELING IS ESSENTIAL FOR HEART
REGENERATION IN HIPPO-DEFICIENT MICE*
Although some vertebrates, such as zebraﬁsh, can regenerate the heart, heart regen-
eration in mammals is limited [61, 11]. Rather than regenerate, human cardiomyocytes
undergo a maladaptive stress response commonly termed “pathologic remodeling,”
including ﬁbrosis and scarring, that leads to heart failure, a leading killer worldwide
[132, 90]. The mammalian heart has a transient regenerative capacity that terminates
by postnatal day 7 (P7) in mice [102]. This observation has led to the idea that manip-
ulating relevant genetic pathways can therapeutically enhance cardiomyocyte regen-
eration.
The Hippo signaling pathway is a kinase cascade that links changes in cellular den-
sity or mechanical stress to changes in cell proliferation [150]. In mammals, Hippo
signaling limits heart size and inhibits cardiomyocyte proliferation during develop-
ment and adult cardiac regeneration [48, 47]. The downstream Hippo effector Yes-
associated protein (Yap) is a transcriptional cofactor that interacts with DNA binding
partners such as Tead. When Hippo activity is high, Yap is phosphorylated by Lats
and is excluded from the nucleus. When Hippo activity is low, such as during early
heart development, Yap shuttles into the nucleus where it promotes cardiomyocyte
proliferation[150]. Yap activity is not only regulated by Hippo kinases but also by
mechanical signaling. In cells subjected to high amounts of mechanical stress, Yap is
preferentially localized in the nucleus and promotes proliferation [89, 6].
Hippo signaling inhibits adult cardiomyocyte regeneration through the Yap effec-
*Parts of this section are from “Actin cytoskeletal remodeling with protrusion formation is essential 
for  heart  regeneration  in  Hippo-deﬁcient  mice”  by Y. Morikawa, M. Zhang, T. Heallen, J. Leach, 
G. Tao, Y. Xiao, Y. Bai, W. Li, J. T. Willerson, J. F. Martin. Science Signaling, 375(8): ra41, May 2015. 
Reprinted with permission from AAAS.
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tor molecule. Hippo deﬁciency due to loss of function of the Salvador (Salv) adaptor
molecule promotes regeneration in mouse models of apex resection, neonatal myocar-
dial infarction, and adult myocardial infarction [47]. Furthermore, overexpression of
a constitutively active form of Yap in the myocardium also enhances regeneration in
adult cardiomyocytes [148, 75].
In this study, we investigated Yap target genes in heart regeneration by perform-
ing ChIP-sequencing (ChIP-Seq) analysis and mRNA expression proﬁling in Hippo-
deﬁcient hearts. Our data indicated that Yap directly regulates genes involved in cell
cycle progression, genes that promote F-actin polymerization, and genes linking the
actin cytoskeleton to the extracellular matrix.
4.1 Results
4.1.1 Yap directly regulates genes encoding proteins that control cytoskeletal
dynamics and cell proliferation
To identify direct transcriptional targets of Yap, we performed ChIP-Seq experi-
ments in Salv conditional knockout (CKO) mutant mouse hearts at P8. We chose P8
because it is a non-regenerative stage in wild-type mouse hearts but is a regenerative
stage in Hippo-deﬁcient mouse hearts (8). We predicted that in P8 Hippo-deﬁcient
hearts, Yap binding would be enriched for genes that are directly involved in cardiac
regeneration. We performed ChIP-Seq experiments with an anti-Yap antibody in dis-
sected Salv CKO mouse hearts and generated libraries that were sequenced by using
an Ion Torrent sequencer [113]. A total of 25 million Yap ChIP-Seq reads were eval-
uated by using Homer [49]. Motif analysis comparing Yap ChIP-Seq reads indicated
that Tead binding elements were among the most enriched peaks, which validated the
speciﬁcity of the ChIP-Seq experiment (Figure 4.1A&B). In addition, we performed
mRNA expression proﬁling of P8 Salv CKO mouse hearts to analyze changes in gene
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expression in Hippo-deﬁcient hearts (Figure 4.2). We then compared differentially ex-
pressed genes to those in the Yap ChIP-Seq datasets to identify direct transcriptional
targets of Yap.
Overlay of the ChIP-Seq and mRNA expression proﬁling datasets revealed that
Yap bound to 928 genes that showed increased expression (Figure 4.1C). From these
data, we generated a list of Yap target genes that included 3 gene categories: cell cycle
progression, cytoskeleton, and both cell cycle and cytoskeleton (Figure 4.1D-H).
To further characterize productive Yap binding sites, we analyzed our ChIP-Seq
dataset for conserved Tead sites and compared our ChIP-Seq data to available DNAase
hypersensitivity (DHS) andH3K27Ac datasets that mark enhancers [96, 93, 12]. Com-
parison of a mouse heart H3K27Ac ChIP-Seq dataset that marks enhancers with the
Yap ChIP-Seq dataset showed that many Yap peaks from Hippo-deﬁcient hearts were
enriched in putative enhancer regions [96] (Figure 4.3A-E).
We validated the transcriptional activity of a subset of genes by using luciferase
assays. We evaluated genes encoding proteins that are involved in both cytoskeletal
remodeling and the linking of the cytoskeleton to the extracellular matrix (ECM), such
as Actrt2, Pkp4, Enah, Fmn2, Sgcd, and Ctnna3. We also tested genomic fragments
from the cell cycle genes Aurkb and Lin9. A luciferase reporter gene was fused to am-
pliﬁed genomic regions containing conserved Yap ChIP-Seq peaks that aligned with
DHS peaks and/or H3K27Ac peaks that also contained Tead binding elements [96, 93]
(Figure 4.3A-D). We also performed chromosome conformation capture (4C) analy-
sis to deﬁne enhancer contact maps for Sgcd and Ctnna3 and compared those maps
to Yap ChIP-Seq data (Figure 4.3C&D). Chromosome conformation capture provides
3-dimensional information about enhancer-promoter interactions and can aid the dis-
covery of previously unknown enhancers [37, 23]. We noted that enhancer-promoter
contact points for both genes includedYap ChIP-Seq peaks, further supporting the con-
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Figure 4.1: Integrated genomic analysis for identifying Yap target genes. (A) Motif
analysis for enriched Yap ChIP-Seq peaks (total number = 35,412 from 2 indepen-
dent biological replicates). De novomotifs and their best matches are shown. (B) The
density of Tead binding motifs within a 500-bp distance of the Yap ChIP-Seq peaks is
shown. (C) Overlay of genes with increased expression in Salv CKOmouse hearts (to-
tal number = 1,706 from 2 mice) and genes annotated from Yap ChIP-Seq peaks (total
number = 10,396). (D) Gene ontology analysis of genes with increased expression in
Salv CKO mouse hearts and with Yap binding peaks (total number = 928). Enriched
terms were calculated by using over-representation statistics and measured by using
Z-scores. (E) Heat map of Yap target genes identiﬁed by the overlay of microarray
and Yap ChIP-Seq genes in the labeled categories. Heat maps show relative expres-
sion between Salv CKO and control mouse hearts. (F-H) qRTPCR validation of Yap
target genes in P8 control (unshaded bar) and P8 Salv CKO (shaded bar) mouse hearts.
n = 3 independent biological replicates. * p < 0.05; ** p < 0.01; *** p < 0.001.
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Figure 4.2: Microarray and Yap ChIP-Seq reproducibility. Microarray was per-
formed on P8 control and Salv CKO mouse hearts (2 biological replicates per group).
Each sample has 3 technical controls. (A) Histograms show the distribution of log-
transformed raw signal values which are approximate to a normal distribution. The
red dotted lines indicate the mean value. (B) Quantile-Quantile plot of log2 (raw sig-
nal value) from control and Salv CKO samples. The x-axes show quantile values of
standard normal distribution. The y-axes show quantile value of log-transformed sig-
nal value. (C, D) Reproducibility of microarray raw signal value in control and Salv
CKO samples. Biological replicates were plotted as x-axis and y-axis values individu-
ally. Linear correlation coefﬁcients were measured, as r is given in each diagram. The
blue lines indicate the line of best ﬁt. (E) Boxplots show that there were no signiﬁcant
outliers among the samples. (F) Differential expressed genes in control and Salv CKO
samples. Individual genes were plotted by using log of fold-change as the x-axis and
-log10 of the p-value as the y-axis index. Differential expression threshold was fold
change of at least 1.5 and p-value of at least 0.05, highlighted in blue. (G) Repro-
ducibility of Yap ChIP-Seq (2 biological replicates). Signal intensities were measured
over input sample in 5 kb bins. Pearson’s correlation coefﬁcient was calculated based
on the basis of log-transformed values.
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Figure 4.3: Preferential expression of Yap target genes in the fetal heart. (A-D)
Genome browser view of Yap ChIP-Seq enriched peaks for the labeled genes. Align-
ments are shown for stage-speciﬁc H3K27Ac ChIP-Seq, DHS, and 4C anchor points
(Ctnna3, Sgcd). For 4C, vp denotes viewpoint and enh denotes enhancer. Grey blocks
show regulatory regions used as luciferase reporters with red lines indicating consen-
sus Tead binding motif. The y-axes of Yap ChIP peaks shows the normalized read
number. (E) Quantiﬁcation of P7 heart H3K27Ac ChIP-Seq reads in the 6-kb range
around Yap ChIP-Seq peaks. n = 2 biologic replicates (F) Luciferase reporter assay
data showing that Yap/Tead co-activated target gene expression through regulatory re-
gions identiﬁed in Yap ChIP-Seq. n = 3 independent transfection experiments. * p <
0.05; ** p < 0.01; *** p < 0.001. (G) Luciferase reporter assay data of Yap enhancers
with or without TEAD motifs. n = 3 independent transfection experiments. All lu-
ciferase constructs were co-transfected with Yap and TEAD expression vectors. ***
p < 0.001 (Mann-Whitney), n.s. not signiﬁcant. Error bars are standard deviations.
Activity was normalized to that of pGL3 vector.
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clusion that Yap peaks were found in enhancer regions. Thus, we generated luciferase
reporter constructs containing the Yap peaks that were also 4C contact points.
The transfection of cells with a Yap expression vector trans-activated enhancer
elements of these genes in vitro in amanner that required Tead2 co-transfection (Figure
4.3F&G). Moreover, deletion of the Tead elements resulted in loss of enhancer activity
in all genes with the exception of Enah. It is possible that Enah has a poorly conserved
Tead element that we failed to identify or that Yap may bind Enah by cooperating with
a different DNA binding partner (Figure 4.3F&G). Together, these data support the
hypothesis that Yap directs the transcription of genes promoting cell cycle progression,
genes that link the actin cytoskeleton to the ECM, and genes that remodel the actin
cytoskeleton.
4.1.2 Yap target genes are preferentially expressed in the fetal heart
We analyzed human RNA-Seq data to determine whether orthologs of our Yap
target genes are more highly expressed in human fetal or adult hearts. This analysis
indicated that the expression of most Yap target gene orthologs was higher in human
fetal hearts than in adult hearts [12] (Figure 4.4A&B). Comparison of the human fetal
RNA-Seq data with genes that we found had increased expression in SalvCKO hearts
indicated an enrichment in fetal hearts for genes that encode cell cycle and cytoskeletal
proteins (Figure 4.4C). In addition, genes encoding proteins typical of the adult heart,
including lipid metabolism and muscle contraction proteins, had reduced expression in
Salv CKOmouse hearts (Figure 4.4D). This is consistent with ﬁndings that developing
and early postnatal hearts rely on glycolytic metabolism rather than lipid oxidation and
have an immature contractile apparatus [82]. We also compared our Yap target gene
set to mRNA expression data from P4 rat cardiomyocytes overexpressing Yap. Almost
all Yap targets we identiﬁed had higher mRNA levels in the Yap gain of function rat
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cardiomyocytes (ﬁg. S2E) [134].
Analysis of DHS datasets from human fetal and adult hearts further supported the
hypothesis that Yap binding sites are enriched in fetal heart genes [88, 130]. Motif
analysis from the human fetal and human adult DHS data indicated that Tead elements
were highly enriched in human fetal heart DHS peaks, along with recognition elements
for other important cardiac development transcription factors such as Tbx and Mef2
(Figure 4.5A). Although Tead elements were enriched in human fetal heart DHS peaks,
this was not the case for DHS peaks from human embryonic stem cells, supporting the
cardiac tissue enrichment of Tead binding activity (Figure 4.5B). Tead elements were
also found in DHS peaks from tissues such as the kidney and lung indicating that Tead
elements are not cardiac speciﬁc (Figure 4.5C). Tead elements were enriched in fetal
heart DHS peaks even for genes whose physical location was not conserved between
humans and mice (Figure 4.5D-F). These data support the hypothesis that Yap and
Tead enhance the expression of fetal cardiac genes.
4.1.3 Hippo-deﬁcient adult cardiomyocytes are proliferative
We evaluated proliferation and apoptosis in adult and neonatal control and Salv
CKO mutant mouse hearts after inducing myocardial infarction by left anterior de-
scending artery occlusion (LADO; Figure 4.6). Compared to controls, Salv CKO mu-
tant mouse hearts showed an increased number of EdU-positive cardiomyocytes at 4,
10, and 15 days post myocardial infarction for adults (Figure 4.6A-C) and 1 day post
myocardial infarction for P8 neonatal hearts (Figure 4.6C). Notably, S-phase entry was
induced by Hippo deﬁciency and not by injury, as shown by equivalent amounts of
EdU incorporation in Hippo-deﬁcient sham hearts and Hippo-deﬁcient injured hearts
(Figure 4.6C). The number of M-phase cardiomyocytes, as indicated by Aurora B im-
munostaining, was higher in Hippo-deﬁcient injured hearts than in Hippo-deﬁcient
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Figure 4.4: Yap target genes are enriched in the fetal heart. (A) Heat map of Yap tar-
get gene expression in human fetal and adult ventricle (n = 2 biological replicates for
each). The color bar represents relative expression level of log-transformed value for
each gene across different samples. (B) Yap target gene orthologs are more highly
expressed in human fetal hearts than in adult hearts. Gene expression was measured
in RPKM by using RNA-Seq proﬁling data. n = 2 independent biological replicates.
(C, D) Gene ontology analysis for genes enriched in fetal (C) (total gene number =
700) and adult hearts (D) (total gene number = 417). x-axes indicate Z-score of over-
representation statistics; y-axes indicate percentage of gene overlay with differentially
expressed genes from Salv CKO hearts. (E) Target gene expression in postnatal day 4
neonatal rat cardiomyocytes transduced with lacZ or YAP1 (S127A) expressing aden-
ovirus (data extracted from GSE33019, n = 4 biological replicates per group. ** false
discover rate (fdr) < 0.01; * fdr < 0.05.
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Figure 4.5: Yap/Tead regulatory elements are enriched in fetal heart DNaseI hypersen-
sitivity sites (DHS) and Yap binding peaks. (A) Matched motifs in human fetal heart
DHS-Seq peaks (n = 11 biological replicates). Human fetal heart-speciﬁc DHS peaks
were compared to human adult heart DHS peaks (n = 2 biological replicates). Enriched
motifs represent fetal heart-speciﬁc DHS peaks. (B) The density of enriched motifs
within a 500 bp range of human fetal heart DHS peaks are shown in comparison with
that of human embryonic stem cell DHS peaks (grey). (C) Heat map of enriched mo-
tifs in DHS footprints from different adult tissues and fetal vs. adult comparison. The
relative enrichment was measured by the number of footprints containing each mo-
tif. (D-F) Representative genome browser tracks of Yap targets in regions of genome
that are not conserved between species. DHS-Seq peaks from human fetal (green) and
adult (blue) hearts and Yap ChIP-Seq peaks from mouse P8 Salv CKO hearts (black)
are shown. Fgd4 contains highly conserved Tead binding elements in the promoter
region (D). In Crebbp (E) and Mad2l1 (F), fetal speciﬁc DHS peaks and Yap binding
peaks are located in genomic regions that are not conserved between species (non-
syntenic).
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sham hearts (Figure 4.6D-G). This indicates that Hippo-deﬁcient hearts respond to in-
jury by progressing through cytokinesis more efﬁciently than do Hippo-deﬁcient sham
hearts.
The number of apoptotic cells in the myocardium was similar between control and
Salv CKO mice after LADO (Figure 4.6H). Moreover, there was no evidence for a
higher frequency of cell fusion events in Salv CKO mutant mouse hearts.We also ex-
amined cell size at multiple stages after myocardial infarction and found that SalvCKO
mouse cardiomyocytes were smaller than those of controls. We conclude that Salv
CKO mouse cardiomyocytes showed increased EdU incorporation for 15 days post
myocardial infarction and that after injury, Salv CKOmouse cardiomyocytes progress
through M-phase more efﬁciently than do cardiomyocytes of sham mouse hearts.
In the border zone of Salv CKOmouse hearts, nuclear localized Yap was increased
(Figure 4.6I-M), suggesting the possibility that the expression of Yap-regulated genes
may also be increased in the border zone of the regenerating heart. To examine this
possibility, we isolated RNA from dissected border zones of Salv CKO mouse hearts
and control hearts 4 days after inducing myocardial infarction. Quantitative real-time
PCR (qRT-PCR) analysis revealed that Yap target genes had increased expression in
the border zone of SalvCKO mouse hearts as compared to that of controls (Figure
4.6N).
4.1.4 Hippo-deﬁcient cardiomyocytes extend sarcomere-ﬁlled protrusions
Our ﬁnding that Yap-regulated genes encode proteins that regulate the actin cy-
toskeleton suggests that Hippo-deﬁcient cardiomyocytesmay have different cytoskele-
tal characteristics than control cardiomyocytes. We examined cardiomyocytes at 4, 7,
and 10 days after myocardial infarction in adult control and Salv CKO mouse hearts.
No differences in cellular morphology were observed between control and Salv CKO
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Figure 4.6: DNA synthesis and Yap localization in border zone cardiomyocytes dur-
ing adult heart regeneration. LAD occlusion was performed onMyh6-CreErt; mTmG
(control) and Myh6-CreErt; Salvfx/fx; mTmG (SalvCKO) mice, and hearts were col-
lected at 1, 4, 10, and 15 days post myocardial infarction (dpmi). (A, B)De novoDNA
synthesis was detected by measuring EdU incorporation in control (A) and SalvCKO
(B) mouse hearts at 10 dpmi. Red arrowhead shows EdU-stained nucleus. Bars = 50
μm. (C) Quantiﬁcation of de novo DNA synthesis in the border zone at 1, 4, 10, and
15 dpmi or in sham mice (n = 3 independent biological replicates for each genotype
and time point). *p < 0.05. (D-F) Cytokinesis was detected with Aurora B kinase im-
munostaining in control (D) and Salv CKO (E, F) mouse hearts at 10 dpmi. Arrow
shows staining in non-cardiomyocyte, and arrowheads show staining in cardiomy-
ocytes. Bars = 20 μm. (G, H): Quantiﬁcation of Aurora B kinase (G) and TUNEL
activity (H) (n = 3 independent biological replicates for each genotype). ** p <0.01.
(I-M) Yap localization in border zone of control (I, J) and Salv CKO mouse hearts (K,
L) at 10 dpmi. Arrowheads show nuclear localized Yap. Bars = 50 μm. (M) Quantiﬁ-
cation of nuclear Yap in border zone cardiomyocytes at 10 dpmi (n = 3 independent
biological replicates for each genotype). * p < 0.05; remaining column comparisons
were nonsigniﬁcant. (N) Gene expression of Yap downstream target genes were quan-
tiﬁed with qPCR in border zones from heart tissues after myocardial infarction. Border
zone is deﬁned as tissue adjacent to the scar (n = 3 biologic replicates) ** p <0.01, ***p
<0.001 Figure credit: Yuka Morikawa, Todd Heallen
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mouse hearts until 7 days post myocardial infarction, when the Salv CKO mouse car-
diomyocytes showed more prevalent sarcomere breakdown in the border zone (Figure
4.7A-G). At 10 days post myocardial infarction, adult Salv CKO mouse cardiomy-
ocytes, but not those from control mice, showed extended protrusions into the scar
(Figure 4.7C, F, &G). Immunoﬂuoresence experiments performed by using anti-talin
and anti-vinculin antibodies that recognize costameres linking the ECM to the actin cy-
toskeleton through the integrin-vinculin-talin complex revealed that the distribution of
both talin and vinculin [153] was markedly expanded in the cardiomyocytes of adult
Salv CKO mice at 10 days post myocardial infarction (Figure 4.7H-O). Protrusions
were commonly seen on multiple sections surrounding the infarct in adult Salv CKO
mouse cardiomyocytes but not in those of control mice.
In the apex resection model, a deﬁned region of cardiac apex is removed, allow-
ing for the accurate characterization of renewing cardiomyocytes [102]. Cells derived
from the cardiomyocyte lineage were observed in the resected zone that contained a
large number of non-cardiomyocyte cells. Similar to what we observed in adult mouse
hearts aftermyocardial infarction, Hippo-deﬁcient cardiomyocyte lineage–derived cells
extended cellular protrusions and showed evidence for extensive remodeling of vinculin-
positive focal adhesions. In control mouse hearts, border-zone GFP-positive cells did
not inﬁltrate the resected region of the heart or remodel vinculin.
4.1.5 Hippo-deﬁcient cardiomyocytes mobilize into collagen gels
Our ChIP-Seq and immunoﬂuorescence data support the notion that Salv CKO
mouse cardiomyocytes display extensive cytoskeletal remodeling with protrusive ac-
tivity. Because cellular protrusions are characteristic of migrating cells [109], we de-
termined whether Salv CKO mouse cardiomyocytes are capable of mobilizing into
a collagen gel. Cardiomyocytes from cardiac explants from Salv CKO mice, but
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Figure 4.7: Cardiomyocyte morphological change and cytoskeleton rearrangement
during adult heart regeneration. LAD occlusion was performed on the hearts of
Myh6-CreErt; mTmG (control) andMyh6-CreErt; Salvfx/fx; mTmG (SalvCKO) mice.
Control (A-C) and SalvCKO (D-F) mouse hearts were stained for the cardiomyocyte
marker cTNT to visualize morphology of the cardiomyocytes in the border zone at 4,
7, and 10 dpmi (n = 3 independent biological replicates for each genotype and time
point). Arrows show cardiomyocytes with sarcomere disassembly. Arrowheads show
cardiomyocyte protrusion. Bars = 50 μm. (G) Quantiﬁcation of protrusions. Car-
diomyocytes adjacent to the scar were analyzed for length and number of protrusions
at 10 dpmi. One hundred cardiomyocytes from each biological replicate were analyzed
(n =3 independent biological replicates). * p < 0.05. Control (H, I) and SalvCKO (J,
K) mouse heart sections at 10 dpmi were stained for Talin (n = 2 independent biologi-
cal replicates). Arrows show increased Talin staining in border zone cardiomyocytes.
Bars = 25 μm. Control (L, M) and SalvCKO (N, O) mouse heart sections at 10 dpmi
were stained for the focal adhesion molecule vinculin. Arrowheads show the rear-
rangement of vinculin in the protruding front of the cardiomyocytes (n = 3 independent
biological replicates). Bars = 25 μm. Figure credit: Yuka Morikawa, John Leach
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not those from control mice, efﬁciently migrated into collagen gels (Figure 4.8A-E).
Therefore, our ﬁndings suggest that SalvCKO mouse cardiomyocytes extend protru-
sions that are sufﬁcient for cellular movement into a collagen gel. We also used the
collage invasion assay to test whether the small interfering (si) RNA-mediated knock-
down of Salv promotes cell migration into the gel. siRNA knockdown experiments
in P19 embryo carcinoma cells revealed that the siRNA-mediated knockdown of Salv
resulted in increased cell invasion into the gel that was not due to increased cell pro-
liferation (Figure 4.8F-L). In addition, the siRNA-mediated knockdown of the Yap
target genes Fgd4, Pkp4, and Talin2 resulted in decreased cell migration into collagen
gels. Furthermore, the simultaneous siRNA-mediated knockdown of both Salv and
Talin2 showed that the knockdown of Talin2 suppressed the Salv knockdown pheno-
type. Moreover, treating P19 cells with verteporﬁn, a small molecule that disrupts
Yap-Tead interaction, blocked the migration of P19 cells into the gel (Figure 4.8L)
[81].
4.1.6 The dystrophin glycoprotein complex is required for cardiac regeneration
Many Yap target genes encode proteins that link the actin cytoskeleton to the sar-
colemma and ECM. Sarcoglycan delta (Sgcd) and Syntrophin B1 (Sntb1) are both
DGC components that connect the actin cytoskeleton to the extracellular matrix and
transmit force from muscle cells to the extracellular matrix [9, 39]. Sgcd is mutated
in human patients with limb-girdle muscular dystrophy and is thought to stabilize the
plasma membrane in response to mechanical stress [135]. qRT-PCR and Western blot
analyses showed that the abundance of Sgcd mRNA and Sgcd protein was increased in
SalvCKO mouse hearts when compared with control mouse hearts (Figure 4.9A&B).
After myocardial infarction, Sgcd mRNA levels were increased in both control and
SalvCKO mouse hearts. The abundance of Sgcd protein was not further increased af-
75
Figure 4.8: Cardiomyocyte migration through collagen. Collagen migration assays
were performed with P8 cardiomyocytes from control (Myh6-CreErt; mTmG)(A,
C) or SalvCKO (Myh6-CreErt; Salvfx/fx; mTmG) mouse hearts (B, D). Cardiomy-
ocyte lineage was visualized with eGFP and non-cardiomyocytes were visualized with
mTomato. (A, C) Whole gel view. Arrowheads show migrated cardiomyocytes.
Bars=250 μm. (B, D) High-magniﬁcation images of the area with eGFP positive cells.
Bars=50 μm. (E) Quantiﬁcation of the number of hearts in which migration was ob-
served for each genotype (n = 6 hearts per genotype). p = 0.002, control vs. SalvCKO
mice. (F-K) P19 cell migration in collagen gel after siRNA treatment.with the labeled
siRNA Bars = 250 μm. (L) Quantiﬁcation of migrated cells after each treatment. Cells
were treated with either siRNA or Yap inhibitor verteporﬁn (VP). n = 3 biologic repli-
cates for all groups. Figure credit: Todd Heallen, Yuka Morikawa
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ter myocardial infarction, suggesting the posttranscriptional regulation of Sgcd (Fig-
ure 4.9A&B). Western blot analysis indicated that Sntb1 protein abundance was un-
changed between control and SalvCKO mouse hearts. We next fused the region of
the Sgcd gene containing the Yap/Tead binding element to a luciferase reporter gene.
Luciferase assays revealed that Yap and Tead2 transactivated the Sgcd reporter gene
but not a Sgcd reporter with a mutated Tead element (Figure 4.9C).
Yap is required for mammalian heart regeneration during the postnatal regenera-
tive period [148]. Therefore, we examined whether the Yap target gene Sgcd and its
functional activity in the DGC are also required for cardiac regeneration. As a model
for impaired DGC, we used Mdx mutant mice that harbor a null dystrophin mutation
that disrupts the DGC. Cardiac apexes from Mdx and control mice were amputated at
P1, when regeneration is possible [102]. Whereas control mouse hearts had a robust
regenerative capacity, allMdx mouse hearts formed a large scar (Figure 4.9D-F). Fur-
thermore, cardiac function as measured by ejection fraction and fractional shortening
was compromised in resectedMdxmouse hearts (Figure 4.9G).
4.1.7 The dystrophin glycoprotein complex is required for cellular protrusions
We examined the border zone of control and Mdxmouse hearts 4 days after re-
section. No difference was observed in the amount of nuclear localized Yap between
Mdxand control mouse hearts, suggesting that DGC function is dispensable for the
shuttling of Yap from the nucleus to the cytoplasm during regenerative stages (Figure
4.10A-E). Whereas cardiomyocytes of control mice exhibited extensive cytoskeletal
remodeling with protrusion formation, Mdxmouse cardiomyocytes failed to remodel
their cytoskeleton and extend protrusions (Figure 4.10F-H). Using collagen gel as-
says to functionally evaluate protrusive activity, we found that explanted myocardial
cells from control mice were competent to move through a ﬁlter into a lower collagen
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Figure 4.9: The dystrophic complex is downstream of the. Hippo pathway and is
required for cardiac regeneration (A, B) LADO and sham surgery were performed
in control and SalvCKO mouse hearts at P8, and heart samples were collected at 4
dpmi. (A) Delta-sarcoglycan (Sgcd) mRNA was detected in control and SalvCKO
mouse hearts by using qRT-PCR and was quantiﬁed by normalization to Gapdh (n =
3 for all groups). (B) Sgcd protein was detected by using Western blot analysis (n
= 3 hearts per genotype and treatment). Sgcd band intensities were quantiﬁed and
normalized to those of alpha-tubulin. ***p < 0.001, remaining column comparisons
were non-signiﬁcant (n.s.) (C) Luciferase assays were performed with P19 embryonal
carcinoma cells. Cells were transfected with either the control luciferase reporter, a
reporter containing the Sgcd enhancer, or a reporter containing the Sgcd enhancer but
lacking the Tead site. Three independent experiments with technical triplicates were
performed. *p < 0.05. (D-G) Dystophin glycoprotein complex (DGC) is required for
endogenous cardiac regeneration. (D, E) Representative images of trichrome-stained
heart sections from B10 control (D) and Mdx-B10 (E) mice subjected to resection of
the cardiac apex. Bars = 500 μm. (F) Quantiﬁcation of the scar size at 21 dpr in B10,
(n = 11), B6/10 (n = 4), Mdx-B10 (n = 7), and Mdx-B6/10 (ittn = 6) mouse hearts.*p
< 0.05, ***p < 0.001. (G) Echocardiography analysis of control sham (n = 3), control
apex resection (n = 7),Mdxsham (n = 4), andMdxapex resection (n = 7) mouse hearts
21 days after surgery. *** p < 0.001, remaining column comparisons were n.s. Figure
credit: John Leach, Todd Heallen
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gel, whereas myocardial cells fromMdxmice failed to do so (Figure 4.10I-L). We also
performed EdU incorporation and AurkB immunoﬂuorescence assays to determine
whether Mdxmouse cardiomyocytes had a proliferative defect that was responsible
for failed regeneration. We found that EdU incorporation and AurkB immunoreactiv-
ity were equivalent between cardiomyocytes of Mdxand control mice. Proliferation
was increased equally in both control and Mdxmouse hearts after injury, supporting
the notion that Mdxmice failed to regenerate the heart because of a defect in myocar-
dial protrusive activity rather than because of a proliferative defect. To determine
whether dystrophin inhibition could suppress the increased cell migration phenotype
observed in Salv knockdown cells, we concomitantly knocked down Salvand Dmd in
p19 cells and evaluated cell migration. Indeed, knocking down both Dmd and Salvin
p19 cells suppressed the increased cell migration observed in Salvknockdown cells
(Figure 4.10M-Q).
4.2 Discussion
Mobilization of endogenous cardiomyocyte regenerative capacity may be a vi-
able option for deﬁnitive heart failure therapy. Hippo pathway loss of function or
Yap gain of function promotes cardiomyocyte regeneration after myocardial infarc-
tion [47, 148, 75]. In this study, we identiﬁed direct Yap transcriptional target genes
and discovered the importance of cytoskeletal remodeling with cellular protrusions in
heart regeneration. Yap target genes directly control cell shape and protrusive activity.
4.2.1 Yap regulates genes encoding proteins that link the ECM to the actin
cytoskeleton
Cardiomyocytes constantly sense and interpret local microenvironment rigidity
[66]. Yap-regulated genes, including Ctnna3, Sgcd, and Tln2 are important for link-
ing the actin cytoskeleton to the ECM. Our data, along with data showing that Yap
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Figure 4.10: Regulation of cardiomyocyte protrusion by the dystrophin complex. (A-
D) Yap localization in border zone cardiomyocytes of B6/10 control (A, B) andMdx-
B6/10 (C, D) mouse hearts at 4 dpr. Arrows show nuclear localized Yap. Bars = 25
μm. (E) Quantiﬁcation of nuclear Yap in border zone cardiomyocytes at 4 dpr (n =
3 per genotype). *p < 0.05. (F-H) DGC is required for cardiomyocyte protrusion.
Sections of the border zone of B6/10 control (F, G) and Mdx-B6/10 (H) mouse hearts
were stained with the cardiac marker cTnt at 4 dpr. Arrows show protruding cells at
the border zone. Panel G is a higher magniﬁcation image of F. For F and G, bars = 50
μm; for G, bars=25 μm. (I-K) Collagen gel assay for P1 B10 (I, J) and Mdx-B10 (K)
hearts. Panel J is a higher magniﬁcation image of I. For I and K, bars = 100 μm; for
J, bars = 20 μm. (L) Quantiﬁcation of the migration observed in B10 control (n = 11)
and Mdx-B10 (n = 6) mouse cardiomyocytes. p = 0.035, control vs. Mdx. (M-P) P19
cell migration in collagen gel after labeled siRNA treatment. Negative control (M),
Salv(N), dystrophin (dmd) (O), and Salvand dmd combined (P). Bars = 250 μm. (Q)
Quantiﬁcation of migrated cells after each treatment. n = 3 for all groups. * p < 0.01.
Figure credit: John Leach, Yuka Morikawa, Todd Heallen
80
subcellular localization is regulated by matrix rigidity, support the idea that Yap in-
terprets and responds to local ECM mechanical characteristics [6, 31]. Yap-regulated
genes are components of 2 plasmalemmal complexes that link the actin cytoskeleton
to the ECM: the DGC and the talin-vinculin-integrin complex [3]. These genes in-
clude the DGC component Sgcd and the actin-binding protein Talin2, which links the
actin cytoskeleton to integrins and ECM. Other Yap-regulated genes such as Ctnna3, a
cadherin-associated gene localized to the intercalated disc (ICD), connect the actin cy-
toskeleton to both the ICD and ECM and most likely function to sense tension between
cardiomyocytes [72]. Linking complexes are critical for cardiac muscle homeostasis.
The DGC is disrupted in multiple types of muscular dystrophy with dilated cardiomy-
opathy (DCM). Mutations in Vinculin also cause DCM in humans [86]. Likewise, loss
of function mutations in Ctnna3 result in DCM, revealing a critical requirement of this
protein in cardiomyocyte homeostasis [72]. Our molecular ﬁndings suggesting that the
myocardium is linked to the ECM more efﬁciently in SalvCKO mouse hearts are also
supported by the previously reported observation that Lats1/2mutant myocardium can
transmit tissue deformations more effectively, as determined by using optical coher-
ence tomography [140].
4.2.2 Actin cytoskeleton remodeling with cellular protrusion is required for heart
regeneration
In the border zone of SalvCKO mouse hearts, we observed changes in cellular
phenotypes, including the appearance of sarcomere-ﬁlled protrusions surrounding the
wound in apex resection and adult myocardial infarctionmodels. Our data also showed
that SalvCKO mouse cardiomyocytes have the ability to invade a collagen gel. Pro-
trusive activity was observed in both apex resection and adult LADO contexts. Our
genomic analyses indicated that Yap regulates genes promoting lamellipodia forma-
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tion and actin cytoskeleton protrusion. Certain Yap target genes encode proteins that
localize to lamellipodia and ﬁlopodia such as Enah, an Ena/VASP actin regulator that
causes cardiac dysfunction when disrupted in mice [87]. Fgd4, another Yap target
gene, is mutated in Charcot-Marie-Tooth type 4H disease. Fgd4 encodes an F-actin
binding protein with RhoGEF activity speciﬁc for Cdc42, which is crucial to ﬁlopodia
and lamellipodia formation and is essential for cytokinesis [141].
The Yap target gene Mtss1, also named missing in metastasis (MIM), encodes a
protein that localizes to adherens junctions where it promotes actin ﬁlament assembly.
Mtss1 induces the formation of lamellipodial microspikes and membrane rufﬂes that
contribute to protrusions and may be involved in the sensing of ﬂuid shear stress in
the kidney [114]. Other ﬁndings indicate that Mtss1 is required for neural tube clo-
sure [79]. Intriguingly, Yap is regulated by polymerized F actin, which promotes Yap
nuclear localization, suggesting a positive feedback loop that maintains nuclear Yap
localization and cellular protrusions.
4.2.3 Yap directly regulates genes encoding proteins that promote cell cycle
progression and cytokinesis
Our ﬁndings indicated that apoptosis is unaffected in SalvCKOmice after myocar-
dial infarction. Similar ﬁndings were previously reported for Yap gain-of-function
mice [75]. Our Yap target gene dataset indicated that Yap directly regulates multiple
genes that enhance progression throughmultiple cell cycle phases and cytokinesis. Yap
directly activated the cytokinesis genes, Aurkb and Birc5. Another direct gene target of
Yap, Lin9, encodes aMuvB complex component that enhances mitotic gene expression
[115]. Interestingly, considerable cross-talk has been reported between the MuvB and
Lats2 in senescent cells, which warrants further investigation [131]. Other direct gene
targets of Yap identiﬁed in our study included Spin1, a cytokinesis-associated gene ex-
82
pressed in cardiomyocytes, and Aspm, which is mutated in microcephaly patients and
is required for proper spindle orientation and cytokinesis. The expression of Aspm is
increased in cardiac hypertrophy, and it promotes Wnt signaling in neurogenesis [76].
Yap target genes identiﬁed in our study also included Bub1b and Mad2l, compo-
nents of the spindle assembly checkpoint that ensure mitotic ﬁdelity. Bub1b gain of
function extends lifespan and inhibits aneuploidy and chromosome instability. In ad-
dition, other Yap target genes identiﬁed in this study were the cell cycle genes Ccne2
and Cdk6, which play important roles in G1 progression. Moreover, the genes that
encode 2 inhibitors of cell cycle progression, Cdkn2b and Cdkn3, were identiﬁed as
Yap targets that likely function in a negative feedback mechanism. In some contexts,
Cdkn3 may act to promote proliferation via poorly understood mechanism(s) [149].
4.2.4 Yap promotes the expression of its target genes that are more highly expressed
in the fetal heart: evidence for dedifferentiation
Yap promoted the expression of its target genes in the postnatal heart, revealing
a molecular mechanism for fetal gene program reversion that has been described but
poorly understood mechanistically. Consistent with our molecular data, border zone
cardiomyocytes of Hippo-deﬁcient mouse hearts displayed amore primitive cardiomy-
ocyte phenotype with more sarcomere disassembly than did border zone cardiomy-
ocytes of control mouse hearts, suggesting that Hippo-deﬁcient cardiomyocytes dedif-
ferentiate after injury. Cardiomyocyte dedifferentiation also occurs in zebraﬁsh heart
regeneration, implying that there are retained mechanisms between ﬁsh and mammals
[56]. The mechanisms for sarcomere disassembly in the context of regeneration are
poorly understood but may involve regulated protein degradation.
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4.3 Materials and methods
4.3.1 Mice
Mouse strains used in this study were as follows: Myh6-CreErt; mTmG, Myh6-
CreErt; Salvfx/fx; mTmG [47]. C57BL/10J (B10), B10 crossedwith C57BL/6J (B6/10),
C57BL/10ScSn-Dmdmdx/J (Mdx-B10), andMdx crossed with B6 (Mdx-B6/10). B10,
B6, and Mdx-10 mice were obtained from Jackson Laboratory.
4.3.2 ChIP-seq analysis
Immunoprecipitation was performed with an anti-Yap antibody (Novus) in whole-
heart lysates to generate libraries that were then sequenced by using an Ion Proton
sequencer (Life Technologies). Two biological replicates were performed, and the
reproducibility between samples was assessed by using Pearson’s correlation coefﬁ-
cient. About 24 million Yap binding reads were evaluated by using a Homer software
package.
4.3.3 Microarray and ChIP-seq analysis
Microarray analysis was performed on a Phalanx Mouse OneArray v2 platform.
Two biological replicates, each with 3 technical replicates, were collected for each
genotype. The value distribution of raw intensity from a total of 4 samples was graph-
ically viewed in box plots. Linear correlation coefﬁcients between biological replicates
were measured by using R software function var.
Differentially expressed genes were detected by using the R bioconductor package
Limma, version 3.16.8. Brieﬂy, log transformation was performed to the raw intensity
values; a Student t test was performed to identify differences inmRNAexpression level
between control and Salv CKO mouse hearts for each probe. Differentially expressed
genes were called by using the cutoff p-value ≤ 0.05 and fold change ≥ 1.5. Activated
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Yap1 targets were extracted from dataset GSE33019 by using the same criteria.
Ion Torrent Proton reads were mapped to the mm9 assembly (NCBI Build 37) by
using Torrent Suite (2.0.1) aligner Tmap (0.2.3) (Life Technologies). Two biological
replicates were performed. Only uniquely mapped reads were kept. A total of 11 mil-
lion Yap ChIP-Seq reads were generated from replicate 1 and 13 million from replicate
2. The reproducibility between the 2 runs was measured by using Pearson’s correlation
coefﬁcient to compare signal intensities in 5-kbp bins across the genome (Fig. S1G,
r =0.69). ChIP-enriched peaks were identiﬁed from combined reads by using Homer
v4.2 parameters ﬁndPeaks -style factor -o -i input -tagThreshold 15. The peak size was
calculated automatically as 162 bp. The cutoffs for calling the peaks were read number
enriched over input control values ≤ 4 fold, minimum read number of 15 which limited
Poisson p-value to less than 1e-10. The clonal peaks were ﬁltered out. This process
produced 35,412 enriched peaks. Nearest genes associated to the enriched peaks were
annotated by using the “annotatePeaks” function, and de novo motif discovery was
performed by using the ﬁndMotifsGenome function in Homer.
A total of 1,706 genes had increased expression in SalvCKOmouse hearts and were
overlaid with 10,396 Yap ChIP-Seq binding genes. Overlaid genes were subjected to
over-represented gene ontology analysis by using GO Elite with 5000 permutations.
The false discovery rate was calculated by using the Benjamini-Hochberg correction.
Gene ontology terms were plotted by using the Z score. Only terms with a false discov-
ery rate <0.10 were reported. Microarray and ChIP-Seq data are available through the
NCBI Gene Expression Omnibus (GEO) data repository under accession GSE44103.
4.3.4 Human heart RNA-seq data analysis
Human RNA-Seq data were obtained from Gene Expression Omnibus (GEO) and
DNA Data Bank of Japan (DDBJ). The sample IDs of fetal hearts were SRR643778,
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SRR643779; of adult hearts: GSM1010964, ERR030894. The reads were aligned to
reference genome hg19 by using Tophat. The splicing junctions were detected by using
known annotations. Uniquely mapped reads within exons were counted with HTSeq-
count. Differentially expressed genes were detected by using R package DESeq with
a threshold false discovery rate (FDR)≤0.1. Gene ontology analysis of 700 genes with
increased expression and 419 genes with reduced expression was performed in GO
Elite.
4.3.5 Human DHS-seq data analysis
Mapped human DHS-Seq data were extracted from GEO.We used data for 11 fetal
heart samples (GSM530654, GSM530661, GSM665811, GSM665814, GSM665817,
GSM665824, GSM665830, GSM665831, GSM774203, GSM817220, GSM878630,
bed ﬁle) and 2 adult heart samples (GSM1008559, bam ﬁle); tissue-speciﬁc motif call-
ingwas performed on amouseDNaseI digital genomic footprinting dataset GSE40869.
Peaks enriched in fetal hearts were detected against adult DHS data by using Homer
with the following script: ﬁndPeaks fetal_dhs -style dnase -o auto -i adult_dhs. A
total of 73,949 peaks were called. De novo motif enrichment was performed with the
Homer function ﬁndMotifsGenome. Hierarchical clustering of enriched motifs in each
tissue was computed and visualized on the basis of -log(p-value) by using R package
pheatmap.
4.3.6 Mouse heart H3K27Ac ChIP-seq data analysis
Mouse heart H3K27Ac ChIP-Seq data were available in GEO (GSE52386). Bed-
Graph ﬁles were generated from mapped bam ﬁles by using the HomermakeUCSCﬁle
function and were visualized in the UCSC genome browser. The total read number of
individual samples was normalized to 10 million. P7 H3K27Ac ChIP-Seq data were
used to plot genome-wide density proﬁling within a 6-kb range of Yap binding peaks.
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4.3.7 Left anterior descending coronary artery occlusion and apex resection
Left anterior descending coronary artery occlusion (LADO) was performed as pre-
viously described on P8 or adult (8-10 week old) mice (8). In the postnatal (P8) 1
dpmi mouse study, tamoxifen (0.5 mg) was injected inMyh6-CreErt; mTmG (control)
and Myh6-CreErt; Salvfx/fx; mTmG (SalvCKO) mice 1 day before and 5 min after
surgery. For 8-10 week old mice, tamoxifen (1.5 mg) was injected 7 and 6 days before
and within 2 hours (2mg) after surgery. Hearts were collected at 4, 7, and 15 days after
LADO, and EdU was injected 4 times starting at 3 days before collection of the heart.
Resection of the heart apex was performed on P1 mice as previously described
(8) by using B6/10 or B10 (control) and Mdx( with B6/10 or B10 background) mice.
Hearts were collected at either 4 or 21 days after resection. At 21 days after resection
before collection, echocardiography was performed in resected and sham animals. All
echocardiographic measurements were performed in the Mouse Phenotyping Core at
Baylor College of Medicine. One-way ANOVA with Bonferroni’s multiple compari-
son test was performed for statistical analysis.
After echocardiography, hearts were collected, embedded in parafﬁn, sectioned
(7-µm thickness), and stained by using Masson’s trichrome staining. After images
were documented, scar size was measured by using ImageJ. Every other 3 slides were
documented, and the sizes of the sections with the largest scars were recorded. The
Mann-Whitney U test was performed for statistical analysis.
4.3.8 Edu staining, TUNEL assay, and immunohistochemistry
For the adult mouse study, EdU (5’ethynyl-2’-deoxyuridine) was injected into mice
for 4 consecutive days starting 3 days before the heart was harvested. For the P8
mouse study, hearts were collected at 1 day post myocardial infacrtion, and EdU was
injected within 5 min after surgery and at 4 h before the heart was harvested. For the
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neonatal mouse study, hearts were collected at 4 days post resection, and EdU was
injected 4 h before tissue collection. Hearts were embedded in parafﬁn and sectioned
(7- μm thickness). EdU staining was performed by using the Click-iT EdUAlexa Fluor
647 Imaging kit (Life Technologies). Immunohistochemistry with eGFP or cTNT was
performed to label cardiomyocytes after EdU staining.
The TUNEL assay was performed by using the DeadEnd ﬂuorometric TUNEL
assay (Promega). To mark cardiomyocytes, immunohistochemistry with cTNT was
performed after TUNEL staining.
Immunohistochemistry was performed by using standard protocols. Antibodies
used in this study were as follows: rabbit anti-GFP (1:400 dilution, Abcam), rab-
bit anti-AuroraB kinase (1:200 dilution, Abcam), mouse anti-GFP (1:500 dilution,
Clontech), rabbit anti-RFP (1:200 dilution, Clontech), rabbit anti-Yap (1:200 dilution,
Novus), mouse anti-cTNT (1:200 dilution, Thermo), rabbit anti-talin (1:200 dilution,
Abcam), andmouse anti-vinculin (1:200 dilution, Thermo). Fluorescence imageswere
documented by using a Leica TCS SP5 confocal microscope with Leica LAS AF soft-
ware. All images presented in the manuscript were prepared by using Adobe Pho-
toshop CS5.1 (Adobe Systems). Border zone cardiomyocytes were deﬁned as cells
within 300 µm from the scar.
For the quantiﬁcation of positive cells, 3 biological replicates were collected per
genotype and time points. For each stain, 3 images were captured for each biological
replicate. Cell counting was performed blindly. A total of 100-250 cardiomyocytes
were counted in each image for quantiﬁcation. For the quantiﬁcation of Aurora B
kinase, a total of 10 sections were counted per biological replicate. For quantitation of
protrusions, 100 cells adjacent to the scar were examined for the number of protrusions
(less than 10 μm, 10-20 μm, and greater than 20 μm). The Mann-Whitney U test was
performed for statistical analysis.
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4.3.9 Collagen gel assay with heart tissue
For the study of P10 hearts, Myh6-CreErt; mTmG (control) and Myh6-CreErt;
Salvfx/fx; mTmG (SalvCKO) mice were used. Tamoxifen (0.6 mg) was injected twice
at P8 and P9, and hearts were dissected at P10. Apexes were cut and placed on collagen
gel (Millipore). Tissues were mounted by overlaying collagen gel and were cultured
in DMEM with 10% bovine calf serum (BCS) at 37C. After 5 days, collagen gels
were collected and stained with eGFP. Each gel was analyzed for the presence of car-
diomyocytes that migrated to the bottom gel. If any cardiomyocytes were found in
the bottom gel, it was counted as “migration observed.” The Fisher’s exact test was
performed for statistical analysis.
For the study of P1 hearts, B10 (control) and Mdx-B10 mice were used. Hearts
were harvested at P1, and apexes were collected. Nylon mesh (100 μm) was placed on
the collagen gel, and the tissues were placed on top of the mesh. Tissues were mounted
by overlaying collagen gel and were cultured in DMEMmedia with 10%BCS at 37˚C.
After 5 days, the top gel and nylon mesh were removed, and the bottom collagen gel
was stained with cTNT. Quantiﬁcation was performed as described above.
4.3.10 Luciferase assay and transfection experiments
Each enhancer element was ampliﬁed and cloned into the pGL3-promoter plasmid
(Promega). The primers used are listed in Supplemental Table 1. The Tead motif for
each element was deleted by using the Quick Change XL Site-directed mutagenesis
kit (Agilent Technologies) for Sgcd or Gibson assembly kit (NEB) for Aurkb, Ctnna3,
Enah, Fmn2, and Lin9. The locations and sequences of TEADmotifs are listed in Table
S1. Plasmids were co-transfected with Yap and Tead expression plasmids (7) into P19
embryonal carcinoma cells. Luciferase activity was analyzed by using the Dual Glo
luciferase assay system (Promega). Three independent transfection experiments were
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performed with triplicate wells. Mann-Whitney test was used for statistical analysis.
4.3.11 P19 migration assay
To examine the inﬂuence of Yap target genes on cell motility, we performed siRNA
experiments in P19 embryonal carcinoma cells. siRNA oligos were obtained from In-
tegrated DNA Technologies (Coralville, Iowa). The methods used for siRNA knock-
down experiments have been described previously (8). After 24 hours of siRNA treat-
ment, trypsinized cells were suspended in collagen gel mix (Millipore). Nylon mesh
(20 μm) was applied to solidiﬁed collagen gel spots in 4-well plates, and cell/collagen
mixes were dispensed to meshes. Plates were incubated at 37°C (5% CO2) for 1 h and
α-MEM culture media with 10% fetal bovine serum (FBS) was subsequently added.
After 24 h of culture, the top gel and nylon mesh were removed, and the bottom gel
was immmunostained accordingly. We examined the statistical signiﬁcance of the
differences between groups by using Mann-Whitney U tests. p < 0.05 was considered
signiﬁcant.
4.3.12 Western blotting
Methods for Western Blot quantitation were previously described (7). Primary
antibodies used were anti-α-tubulin (1:8000 dilution; Sigma) and anti-SGCD (1:500
dilution; Santa Cruz Biotechnology). Differences between groups were evaluated for
statistical signiﬁcance by using two-way ANOVA with the post-hoc Bonferroni cor-
rection.
4.3.13 Quantitative PCR
Total RNA was extracted from dissected heart tissues by using the RNeasy Micro
Kit (Qiagen), and the concentration was determined by using an Inﬁnite M200PRO
Nanodrop spectrophotometer (Tecan). First-strand cDNA synthesis was performed by
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using the iScript cDNA synthesis kit (Invitrogen) using 1 μg of total RNA input. For
qRT-PCR, 1 μl of cDNA (1:10 dilution) was added to SYBR Green Jumpstart Taq
Ready Mix (Sigma). Each sample was analyzed in triplicate and run on a StepOne-
Plus Real-Time PCR System (Life Technologies). Mean dCt values for each Yap target
gene were normalized against those of GAPDHmRNA levels, and corresponding ddCt
values were log2-transformed to obtain fold-change values. The standard deviations
of control and mutant samples were calculated within groups. The non-parametric
Mann-Whitney test was performed to determine statistical signiﬁcance of the differ-
ences between control and mutant groups for each target gene (p < 0.05 was considered
signiﬁcant). Sequences of primers used in qPCR experiments are available upon re-
quest.
4.3.14 Cell surface area measurements
Immunoﬂuorescence staining for GFP and DAPI was performed as described pre-
viously [47]. For visualization of cell membranes, samples were incubated with wheat
germ agglutin Alexa Fluor 647 conjugate (1:200 dilution; Life Technologies) for 30
min at room temperature before blocking and primary antibody application. Car-
diomyocyte cell surface area measurements were obtained from multiple transverse
sections in series, and averages were obtained by using ImageJ software. For 4 and 10
dpmi hearts, we used Mhccre-Ert; mTmG (control) and Mhccre-Ert; mTmG; Salvf/f
(SalvCKO) mice. For 21 dpmi and 21 dpmi sham hearts, we used Mhccre-Ert (con-
trol) and Mhccre-Ert; Salvf/f (SalvCKO) mice. Differences between groups were ex-
amined for statistical signiﬁcance by using The Mann-Whitney U tests. p < 0.05 was
considered signiﬁcant.
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4.3.15 4C sequencing and analysis
The 4C templates were generated from P8 SalvCKO mouse hearts (2 biological
replicates), as previously described [124, 125]. HindIII and DpnII were used as ﬁrst
and second restriction enzymes, respectively. Promoter sequences from Ctnna3 and
Sgcd were used to design viewpoint ampliﬁcation primers (Ctnna3 DpnII: 5’ ACTG-
GCTGTGGAGGTTTTGAATTAC;HindIII: 5’ CCCTCTGTATTGACTTTCTATCCC;
SgcdDpnII: 5’ GAAACCCTACTCTGCCTCTACTTC;HindIII: 5’ CAGAGGGACTGGGT-
GCTTCT). Libraries were ampliﬁed from 100 ng of template DNA by using the fol-
lowing PCR protocol: 94°C 2 min, 30 cycles of 94°C 15 s, 56 °C 1 min, 68 °C 1 min.
The libraries were then prepared for Ion Proton Sequencer. Ion Proton reads were sep-
arated by PCR primers. Over 700,000 reads were generated for each viewpoint library.
For extracting unknown contact point sequences, only reads were kept that contained
a recognition restriction enzyme site jointed to the PCR primer and, at most, one sec-
ondary restriction site. After trimming the primer sequences, unknown sequences with
length ≥ 40 bp were kept for aligning against mouse genome mm9. Signiﬁcant contact
points in the proximal range (500 kb) were detected by using a previously described
algorithm [124, 120] and were visualized in the UCSC genome browser.
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5. SUMMARY AND CONCLUSIONS
My dissertation work has focused on using bioinformatic analysis to identify gene
regulatory programs that directly involved in atrial ﬁbrillation and heart regeneration.
Pitx2, a transcription factor that controls transcription of numerous target genes,
is located in proximity to sequence variants in the human genome that are commonly
associated with atrial ﬁbrillation (AF). While previous work focused on Pitx2 dur-
ing development, the current study investigated Pitx2 in postnatal heart. It was pre-
viously unknown whether Pitx2 has distinct postnatal and developmental functions.
The Pitx2 genes was removed from hearts of postnatal mice. Unstressed adult Pitx2
mutant mice display variable R-R interval with diminished P-wave amplitude char-
acteristic of arrhythmias called sinus node dysfunction, an AF risk factor in human
patients. To uncover target genes that are regulated by Pitx2, we used a genome-wide
approach, overlaid differentially expressed genes in Pitx2mutants as well as genes di-
rectly bound by Pitx2, and identify direct targets of Pitx2. Pitx2 target genes encoded
cell junction proteins, ion channels, and critical transcriptional regulators. Importantly,
many Pitx2 target genes have been previously implicated in human AF. Other studies
in adult Pitx2mutant mice revealed structural remodeling in the heart characteristic of
human AF patients. Our ﬁndings provide new mechanistic insight into AF, revealing
that Pitx2 has genetically separable postnatal and developmental functions and un-
veiling direct Pitx2 target genes that include channel and calcium handling genes as
well as genes that stabilize the cellular structure in postnatal atrium. Since Pitx2 reg-
ulates many of these genes in the postnatal heart, it is conceivable that drugs can be
developed to modulate the molecular interaction between Pitx2 and its target genes.
Additionally, we performed chromosome conformation capture combined with high-
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throughput sequencing (4C-Seq) using Pitx2 promoters and regulatory regions over-
laid with atrial ﬁbrillation high-risk locus. Our results indicate direct contacts of Pitx2
promoter and AF-associated enhancer region. We deleted the 20-kb region in vitro,
and found the up-stream enhancer directly regulates Pitx2ab isoform, not Pitx2c. Such
distinct enhancer-promoter speciﬁcity is mediated by genome insulator protein CTCF.
Depletion of CTCF site that segregates Pitx2ab and Pitx2c promoters led to restore of
Pitx2ab expression. Our ﬁndings that many important Pitx2 regulated events occur
postnatally also strengthens the likelihood that Pitx2-mediated atrial ﬁbrillation may
be treatable in the future.
We also identiﬁed key components that are essential for heart regeneration in hippo-
deﬁcient mice. Hippo signaling is an evolutionarily conserved kinase cascade that reg-
ulates organ size during development and prevents adult mammalian cardiomyocyte
regeneration by inhibiting the transcriptional coactivator Yap, which also responds to
mechanical signaling in cultured cells to promote cell proliferation. To identify Yap
target genes that are activated during cardiomyocyte renewal and regeneration, we
performed Yap chromatin immunoprecipitation sequencing (ChIP-Seq) and mRNA
expression proﬁling in Hippo signaling–deﬁcient mouse hearts. We found that Yap
directly regulated genes encoding cell cycle progression proteins, as well as genes en-
coding proteins that promote F-actin polymerization and that link the actin cytoskele-
ton to the extracellular matrix. Included in the latter group were components of the
dystrophin glycoprotein complex, a large molecular complex that, when defective, re-
sults in muscular dystrophy in humans. Cardiomyocytes near the scar tissue of injured
Hippo signaling—deﬁcient mouse hearts showed cellular protrusions suggestive of
cytoskeletal remodeling. The hearts of mdx mutant mice, which lack functional dys-
trophin and are a model for muscular dystrophy, showed impaired regeneration and
cytoskeleton remodeling, but normal cardiomyocyte proliferation, after injury. Our
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data showed that, in addition to genes encoding cell cycle progression proteins, Yap
regulated genes that enhance cytoskeletal remodeling. Thus, blocking the Hippo path-
way input to Yap may tip the balance so that Yap responds to mechanical changes
associated with heart injury to promote repair.
In conclusion, integrated bioinformatic analysis allows discovery of novel gene
regulation programs. Through large-scale analysis, we were able to dissect direct tar-
gets of master regulators like Pitx2 in arrhythmias and Yap in cardiac regeneration.
The philosophy behind the bioinformatic analysis is to extract the similarity between
different systems, such as human and mouse genome, or gene programs involved in
development and regeneration, thus build connection between elements of each sys-
tem. The ultimate goal of bioinformatic analysis is not to abandon bench works but
to narrow down the list of candidate genes and regulatory elements and to facilitate
strong hypothesis for future experimental test. My future work will focus on mathe-
matical models with machine learning to understand the effect of genomic variants in
cardiac development and diseases.
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